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Resumo
Nos u´ltimos anos foram desenvolvidas te´cnicas de alto rendimento na in-
vestigac¸a˜o em biologia. Essas te´cnicas evolu´ıram fornecendo a` comunidade
cient´ıfica instrumentos como: sequenciadores de alta capacidade, que per-
mitem obter milho˜es de fragmentos de DNA ao mesmo tempo; especto´metros
de massa em tandem que permitem a identificac¸a˜o de prote´ınas ou proteomas
completos; ou hibridac¸a˜o de microarrays, usados para determinar a expressa˜o
dos genes atrave´s da identificac¸a˜o de mRNAs presentes na ce´lula num mo-
mento espec´ıfico.
Os microarrays constituem uma te´cnica usada para quantificar a expressa˜o
de genes e analisar fragmentos de genes, prote´ınas ou metabolitos. Tambe´m
teˆm sido utilizados para clarificar elementos espec´ıficos do Dogma Central
da Biologia Molecular, envolvidos no controle da transcric¸a˜o; na busca de
dados que expliquem como a expressa˜o do gene comec¸a a partir do DNA; ou
como o mRNA em associac¸a˜o com os ribossomas e´ traduzido em prote´ınas
no citoplasma da ce´lula.
Dado o enquadramento biolo´gico descrito acima, o Cap´ıtulo 1 introduz os as-
pectos da biologia relacionados com os dados RIP-Chip utilizados nesta tese,
dados esses obtidos por Gama-Carvalho et al. [2006], em que se pretende iden-
tificar os mRNAs associados a PTB e U2AF65 em condic¸o˜es nativas. Estas
duas prote´ınas de ligac¸a˜o a RNA fazem parte do controle po´s-transcripcional
da expressc¸a˜o gene´tica em ce´lulas eucario´tas.
Este cap´ıtulo comec¸a por introduzir conceitos de biologia molecular da ce´lula
tal como o dogma central da biologia molecular, onde os processos de tran-
scric¸a˜o e traduc¸a˜o sa˜o essenciais para manter a vida da ce´lula e onde o cont-
role de expressa˜o gene´tica e´ um aparelho fundamental na regulac¸a˜o da ce´lula.
Como parte do controle da expressa˜o dos genes, o Cap´ıtulo 1 apresenta uma
visa˜o geral do controle pre´- e po´s-transcripcional da expressa˜o dos genes. O
splicing de pre´-mRNAs e´ um passo essencial no controle da expressa˜o po´s-
transcripcional dos genes e envolve factores de splicing tais como as prote´ınas
PTB e U2AF65, sendo U2AF65 exportada para o citoplasma e envolvida em
outras func¸o˜es celulares.
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O Cap´ıtulo 1 mostra como foram obtidos os dados RIP-Chip das prote´ınas
PTB e U2AF65 e apresenta uma breve descric¸a˜o da metodologia utilizada
por Gama-Carvalho et al. [2006] na sua experieˆncia RIP-Chip. Mostra como
a identificac¸a˜o de mRNAs associados a PTB e U2AF65, em condic¸o˜es nati-
vas, foi realizada por imunoprecipitac¸a˜o (IP) apo´s a adic¸a˜o de um anticorpo
monoclonal espec´ıfico (Bb7 anti-PTB mAb ou anti-U2AF65 MC3), seguido
de extrac¸a˜o de RNA, poliadenilac¸a˜o, transcric¸a˜o reversa, etiquetagem final e
amplificac¸a˜o por PCR. Os cDNAs gerados foram hibridados com o GeneChip
Affymetrix Human Genome U133 Plus 2.0 [Gama-Carvalho et al., 2006].
Este cap´ıtulo apresenta uma descric¸a˜o da tecnologia de microarrays, em par-
ticular as caracter´ısticas dos microarrays da Affymetrix utilizados na ex-
perieˆncia RIP-Chip executada por Gama-Carvalho et al. [2006].
De seguida, o Cap´ıtulo 2 apresenta alguns dos me´todos mais comuns de
ana´lise de dados de microarrays e os resultados de seu desempenho nos da-
dos de Gama-Carvalho et al. [2006].
Para a correc¸a˜o de background foi utilizado o modelo linear robusto (RMA)
de Irizarry et al. [2003a] e uma modificac¸a˜o do mesmo (GCRMA) proposta
por Wu et al. [2004], apenas sobre PM (Perfect Match). A normalizac¸a˜o foi
realizada atrave´s da normalizac¸a˜o quart´ılica e a sumariac¸a˜o das sondas foi
feita usando a mediana polish [Irizarry et al., 2003a]. Alternativamente, os
dados foram pre´-processados usando o programa dChip: apenas para PM;
usando o me´todo de normalizac¸a˜o invariant set [Li and Wong, 2001]; e o
me´todo baseado em modelos de Li and Wong [2001] para calcular os n´ıveis
de expressa˜o.
Para efeitos de comparac¸a˜o foram utilizados os dados obtidos apo´s a correc¸a˜o
de background com RMA, a normalizac¸a˜o quart´ılica e sumariac¸a˜o com a me-
diana polish. Com base nestes dados, foi feita a selec¸a˜o de genes enriquecidos
usando as seguintes bibliotecas do BioConductor: limma (ajusta um modelo
linear para cada gene); eBayes (calcula a estat´ısticas T moderada, F e B -
logaritmo das chances a posteriori); decideTests com um valor-p < 0.05
(baseia-se em testes mu´ltiplos para determinar se cada estat´ıstica numa ma-
triz de estat´ısticas T deve ser considerada significativamente diferente de zero
[Smyth, 2004]); RankProd com FDR < 0.05 (teste na˜o-parame´trico que de-
teta itens que sa˜o consistentemente classificados como estando no topo da
lista [Breitling et al., 2004]). Estes resultados foram comparados com os
resultados obtidos com o programa dChip considerando uma taxa de falsas
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descobertas (FDR) < 0.05 e um valor-p < 0.05 [Li and Wong, 2003].
Os resultados apresentados no Cap´ıtulo 2 mostram como diferentes metodolo-
gias aplicadas aos dados de Gama-Carvalho et al. [2006] produziram resulta-
dos diferentes. Parte das diferenc¸as devem-se sobretudo ao facto de mais de
20% dos mRNAs serem enriquecidos e os me´todos de normalizac¸a˜o comuns
terem por base pequenas diferenc¸as entre eles.
Como esta tese teve como principal objetivo o desenvolvimento de metodolo-
gias estat´ısticas para ana´lise de baixo n´ıvel e selec¸a˜o de genes enriquecidos
em experieˆncias RIP-Chip, o Cap´ıtulo 3 e´ dedicado a apresentar a imple-
mentac¸a˜o de um novo me´todo de correc¸a˜o de background inspirado num
me´todo de hibridac¸a˜o na˜o espec´ıfica utilizado para pre´-processamento de da-
dos ChIp-Chip [Johnson et al., 2006]. Modelos de regressa˜o linear foram
usados para modelar em cada microarray a hibridac¸a˜o na˜o espec´ıfica, repre-
sentando interac¸o˜es entre cada treˆs nucleo´tidos consecutivos na sequeˆncia da
sonda. As intensidades das sondas foram padronizadas usando sua intensi-
dade prevista e a variaˆncia das sondas de intensidades previstas semelhantes.
A nova abordagem aqui proposta utiliza a informac¸a˜o de cada microarray de
forma independente, e os valores de intensidade padronizados na˜o revelaram
necessidade de normalizac¸a˜o adicional. Assim, os microarrays podem ser di-
rectamente comparados [Barreto-Hernandez et al., 2011].
O Cap´ıtulo 3 apresenta tambe´m um score para a sonda; a definic¸a˜o de um
valor de enriquecimento da sonda (ENRval) e respectivos valores-p para a
selec¸a˜o de genes enriquecidos [Barreto-Hernandez et al., 2011]. Os genes en-
riquecidos obtidos usando esta metodologia, tanto para os dados RIP-Chip
de PTB como de U2AF65, esta˜o de acordo com os genes identificados exper-
imentalmente por Gama-Carvalho et al. [2006].
Finalmente, o Cap´ıtulo 3 apresenta ao desenvolvimento da uma nova metodo-
logia na˜o-parame´trica baseada em postos (ranks), implementada para selec¸a˜o
de genes enriquecidos e aplicada aos scores propostos en este Cap´ıtulo. Esta
metodologia tem em conta a variabilidade da intensidade padronizada em
cada sonda, em vez de usar o valor de sumariac¸a˜o de cada sonda (ENRval).
Ainda neste cap´ıtulo, as metodologias desenvolvidas nesta tese para a selec¸a˜o
de genes enriquecidos sa˜o aplicadas aos dados da experieˆncia Spike-In. Esta
base de dados foi constru´ıda ha´ alguns anos e e´ usada no desenvolvimento e
comparac¸a˜o de me´todos de ana´lise de expressa˜o diferencial de genes [Irizarry
et al., 2003b]. A experieˆncia Spike-In U133 engloba 42 transcritos adiciona-
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dos a um complexo transcriptoma humano em concentrac¸o˜es que variam
de 0.125pM a 512pM, correspondendo a 14 hibridac¸o˜es separadas com treˆs
repetic¸o˜es te´cnicas. Os transcritos foram inclu´ıdos na experieˆncia sob a forma
de um quadrado latino cla´ssico [Irizarry et al., 2003b]. Para a ana´lise com-
parativa, treˆs diferentes hibridac¸o˜es Spike-In foram selecionadas (hibridac¸o˜es
1, 8 e 14) e usadas para simular diferenc¸as de enriquecimento em experieˆncias
RIP-Chip atrave´s do seguinte procedimento: 1 como Controle e 8 como IP;
1 como IP e 14 como Controle.
As duas metodologias desenvolvidas nesta tese para selec¸a˜o de genes en-
riquecidos, apresentam elevada exatida˜o quando aplicadas aos dados Spike-
In U133.
Palavras-chave: Microarrays, RIP-Chip, Prote´ınas de associac¸a˜o a RNA,
Bioinforma´tica, pre´-processamento.
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Abstract
Pre-mRNA splicing is an essential step in the post-transcriptional gene ex-
pression control involving protein-splicing factors like PTB and U2AF65; the
last one is exported to the cytoplasm and involved in some other cellular
functions. The identification of PTB- and U2AF65-associated mRNAs under
native conditions was performed by immunoprecipitation and hybridization
on Chip (RIP-Chip) technology using the Affymetrix GeneChip R© Human
Genome U133 Plus 2.0.
The aim of this thesis is to develop statistical methodologies for low level anal-
ysis and enriched gene selection in RIP-Chip experiments. When the most
common methodologies for quality assessment, low level analysis (background
adjustment, normalization and summarization) and detection of differentially
expressed genes (DEG), are applied to RIP-Chip data the obtained results
differ. This probably happens because usually more than 20% of the mRNAs
are enriched, while methods for normalization and identification of DEG are
developed supposing that only a small proportion of genes (1% or 5%, say)
express differently. Also, methods for detecting differentially expressed genes
may not be the most adequate for gene enrichment selection.
In this thesis is implemented a background correction method inspired in a
non-specific hybridization method used for pre-processing ChIP-Chip data.
Linear regression models are used in each array to model the non-specific
hybridization. Probe intensities on the array are standardized using their
predicted intensity and the variance of similar predicted intensities. The
standardized probe intensities showed no need for further normalization, so
the scores could be directly compared. It is proposed a probe set score, a
probe set enrichment value and its p-value for enriched gene selection. The
genes selected using this new method are practically the same as the ones
found experimentally. Additionally, a new methodology based on ranks is
presented for enriched gene selection, being applied to the probe set scores
proposed.
Both methodologies had high accuracy when applied to Spike-In U133 dataset,
which is used to benchmark methodologies for analysing Affymetrix microar-
rays.
Keywords: Pre-processing RIP-Chip, RNA binding proteins, linear models,
vii
bioinformatics.
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Preface
In the past few years, the development of the high throughput techniques in
biology research have given to the scientific community several instruments
like: the high capacity sequencers which can get hundreds-thousands DNA
fragments; tandem mass spectrometers that allow identification of cell pro-
teins or proteome; microarrays hybridization and reading, used to determine
gene expression through the identification of mRNA present in the cell at a
moment.
Microarrays constitute a technique used to quantify the difference between
gene expressions and to analyze their fragments as well as proteins or metabo-
lites. They have also been used to clarify specific elements of Central Dogma
of Molecular Biology, involved in transcription control, looking for massive
data on how gene expression begins from DNA or how the kind and amount
of mRNAs is modulated before it reaches the ribosome to start protein syn-
thesis.
Given the biological framework described above, Chapter 1 introduces the
biological aspects related to RIP-Chip data used in this thesis, obtained by
Gama-Carvalho et al. [2006], which aims at looking for the Identification
of PTB and U2AF65-associated mRNAs under native conditions. These two
RNA binding proteins are part of post-transcriptional gene expression control
in eukaryotic cells. This chapter starts with cell molecular biology concepts
like the Central dogma of the molecular biology, where transcription and
translation process are essential for maintaining the cell’s life and where the
gene expression control is a fundamental cell regulatory apparatus. As part
of the gene expression control, Chapter 1 presents an overview of the pre-
and post-transcriptional gene expression control. The pre-mRNA splicing
is presented as an essential step in the post-transcriptional gene expression
control that involved protein-splicing factors like PTB and U2AF65, which
are the last to be exported to the cytoplasm and also implicated in additional
cellular functions.
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Chapter 1 presents how PTB and U2AF65 RIP-Chip data were obtained,
giving a short description of the methodology used by Gama-Carvalho et al.
[2006] in their RIP-Chip experiment. In this chapter is also shown how the
identification of PTB and U2AF65-associated mRNAs under native condi-
tions was performed by immunoprecipitation (IP) after the addition of a
specific monoclonal antibody (Bb7 anti-PTB mAb or anti-U2AF65 MC3),
followed by an RNA extraction, polyadenilation, reverse transcription, end
tagging and PCR amplification. The resulting cDNAs were hybridized on
the Affymetrix GeneChip Human Genome U133 Plus 2.0. [Gama-Carvalho
et al., 2006]
Besides, this chapter presents the microarray technology description, in par-
ticular the characteristics of the Affymetrix microarrays used in the RIP-Chip
experiment run by Gama-Carvalho et al. [2006].
Chapter 2 presents the common microarray data analysis methods and the
results of their performance on Gama-Carvalho et al. [2006] data.
Background correction was performed only on Perfect Match (PM), on raw
intensity scale, using a robust linear model (RMA) [Irizarry et al., 2003a]
and its modification (GCRMA) [Wu et al., 2004]. Normalization was per-
formed considering quartile normalization and the probe set summarization
using median polish [Irizarry et al., 2003a]. Alternatively, the data were
pre-processed using dChip: only for PM; using invariant set normalization
method [Li and Wong, 2001]; and the model-based method on Li and Wong
[2001] for computing expression values.
For comparison reasons, pre-processed data using RMA is used to select en-
riched genes through the following Bioconductor libraries: limma (fits a linear
model for every gene); eBayes (computes moderated t-statistics, F-statistic,
and posterior log-odds B); decideTests with p-value < 0.05 (computes mul-
tiple testing procedures for determining whether each statistic in a matrix
of t-statistics should be considered significantly different from zero [Smyth,
2004]); RankProd with FDR < 0.05 (non-parametric test that detects items
that are consistently highly ranked in a number of lists [Breitling et al.,
2004]). The results were compared to the results obtained using the dChip
program considering a false the discovery rate (FDR) < 0.05 and a p-value
< 0.05) [Li and Wong, 2003].
The results presented in this chapter showed that the application of different
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methodologies on the Gama-Carvalho et al. [2006] data, produced different
results. Basically, part of the differences should be mainly because more
than 20% of the mRNAs detected are differently enriched while the common
normalization methods are based on small differences between them.
Knowing that the purpose of this thesis was to develop statistical method-
ologies for low-level analysis and enriched gene selection in RIP-Chip experi-
ments, Chapter 3 is dedicated to present the implementation of a new back-
ground correction method, inspired in a non-specific hybridization method
used for pre-processing ChIP-Chip data [Johnson et al., 2006]. Linear regres-
sion models were used to model, in each array, the non-specific hybridization,
accounting for interactions between each three consecutive nucleotides into
the probe sequence. Probe intensities on the array were standardized us-
ing their predicted intensity and the probes’ variance for similar predicted
intensities. The new approach proposed here uses the information for each
array in the experiment independently, and the standardized probe intensity
values showed no need for further normalization. Thus, the arrays could be
directly compared between them [Barreto-Hernandez et al., 2011].
Chapter 3 also presents a probe set score; a probe set enrichment value
(ENRval) and its respective p-value for enriched gene selection. The en-
riched genes obtained using the methodology implemented in this work for
both PTB and U2AF65 matched with the experimental information [Barreto-
Hernandez et al., 2011].
Finally, Chapter 3 is dedicated to the development of a new non-parametric
methodology based on ranks, implemented for enriched gene selection on the
probe set scores proposed on Chapter 3. It takes into account the stan-
dardized probe intensity variability in each probe set, instead of using a
summarization value of each probe set (ENRval).
This chapter also shows how the methodologies developed for enriched gene
selection in this thesis were benchmarked using the data of U133 Spike-In
experiment. This database was created a few years ago and is used in the
development and comparison of differential gene expression analysis meth-
ods [Irizarry et al., 2003b]. U133 Spike-In experiment comprises 42 spike
transcripts in a complex human background at concentrations ranging from
0.125pM to 512pM, evolving fourteen separate hybridizations with three tech-
nical replicates. The spike transcripts were put in a classical latin square
experiment [Irizarry et al., 2003b]. For benchmarking, three different Spike-
In experiment hybridizations were selected (hybridizations 1, 8 and 14) and
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used to simulate RIP-Chip enrichment differences, through the following pro-
cedure: 1 as Control and 8 as IP; 1 as IP and 14 as Control.
Both methodologies for enriched gene selection show high accuracy when
they were applied to Spike-In U133 data set [Irizarry et al., 2003b].
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Chapter 1
Biological concepts related to
RIP-Chip data analysis
1.1 Introduction
In recent years, knowledge regarding molecular function of cells has raised
exponentially, thanks to the development of, so-called, high throughput tech-
niques. These techniques evolved from the needs that Human Genome
Project created; providing to the scientific community with the new high
capacity sequencers which can get hundred-thousands DNA fragments; tan-
dem mass spectrometers that allow identification of cell proteins or proteome;
or microarrays hybridization, used to determine gene expression through the
identification of all mRNAs present in the cell at a specific moment.
This has allowed to go from just identifying some DNA fragments, RNAs or
proteins, to the evaluation of all the molecules present at a specific cellular
time under a particular conditions such as a normal or a pathologic state.
Especially, microarray is a technique used to quantify the difference between
gene expressions and to analyze their fragments as well as proteins or metabo-
lites. This technic has also been used to clarify specific elements of Central
Dogma of Molecular Biology involved in the transcription control. Microar-
ray techniques like ChIP-Chip or RIP-Chip have been applied, generating
a massive amount of data providing insight on how gene expression is reg-
ulated from DNA or how the kind and amount of mRNAs are modulated
before they reach the ribosome to start protein synthesis.
Given the biological framework described above, this chapter will introduce
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the Biology concepts related to RIP-Chip data analysis.
1.2 DNA structure
The DNA molecule, as the primary repository of genetic information in living
systems, is constrained to be stable and predictably structured. Since Watson
and Crick [1953] proposed that the human Desoxyribonucleic Acid (DNA) is
a double-stranded helix, where each strand is formed in a combination of 4
different units call nucleotides (a unit of phosphate, desoxyribose and purine
or pirimidine, Figure 1.1): A (adenine), C (cytosine), T (thymine) and G
(guanine); the knowledge and the analytic techniques related to the cell life
cycle have advanced enormously specially with the recently introduction of
the high throughput techniques for genomic, proteomic, etc.
The double helix of DNA has two polynucleotide strands wound around each
other, assembled in the 5’ to 3’ direction by convention. The phosphate group
bonded to the 5’ carbon atom of one deoxyribose is covalently bonded to the
3’ carbon of the next. The purine or pyrimidine attached to each deoxyribose
is projected toward the axis of the helix and each base forms hydrogen bonds
with the one directly opposite it, forming base pairs.
Figure 1.1: The double helix structure of DNA.
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1.3 Central dogma of the molecular biology
Few years later Crick [1970] proposed the protein synthesis and the model
known as the central dogma of the molecular biology (see Figure 1.2), and
from that moment on many researchers around the world were able to study
the mechanisms used by the cell for controlling the proteins production -
molecules responsible for most of cell functions.
Figure 1.2: Central dogma of the molecular biology.
The Central Dogma as originally formulated by Crick, is a negative hypoth-
esis, which states that information cannot flow downwards from the Protein
to the DNA. Its complement, the Sequence Hypothesis is often conflated
with the Central Dogma. Under it, DNA is transcribed to Ribonucleic Acid
(RNA) (Transcription), and RNA is translated into protein (Translation).
More abstractly, information flows upward from DNA, to RNA, to proteins,
and, by extension, to the cell, and, finally, to multicellular systems. [Werner,
2005].
Basically, the central dogma of the molecular biology says that a gene does
not participate directly in the protein synthesis; in eukaryotes, the DNA is
enclosed inside of nuclear membrane while the protein-synthesizing machin-
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ery is outside the structure, in the cytoplasm, and the two never meet. DNA
sends copies of its encoded information to the cytoplasm, by the mRNA.
The protein synthesis is a two-step process: (1) Transcription, (2) Trans-
lation; where the proteins are synthesized as a polypeptide chain of amino
acids that carry out the genetic instructions encoded in an organism’s DNA.
1.3.1 Transcription
Transcription is the process, of synthesized RNA using DNA as a template,
takes place in the nucleus. The synthesized RNA is a single-stranded polynu-
cleotide where T is replaced by U (uracile), there are the same 3′ to 5′ phos-
phodiester bonds between successive nucleotides, and the sugar is a ribose
(-OH on the 2′ position, makes the molecule unstable relative to DNA).
Five general steps may describe this process (Figure 1.3):
1. RNA polymerase binds to a DNA region called the promoter (in eukary-
otes, three of such polymerases exist) and then the two DNA strands
are transitorily separated and placed at the site of RNA synthesis;
2. RNA polymerase adds bases (ATP, CTP, GTP and UTP) that pair
with the DNA. The synthesis requires that the duplex DNA strands
are separated providing a single-stranded template for directing the
sequence of nucleotides to be assembled into RNA, and then come
together again after the polymerase has passed;
3. RNA polymerase reaches a termination signal and the transcription
stops;
4. The new RNA strand is released from the DNA template and
5. the mRNA leaves the nucleus and enters to the cytosol for completing
the protein synthesis [Fuda et al., 2009].
Transcription produces different types of RNAs that in general may be di-
vided in coding a non-coding RNAs, the last one is involved in the gene
expression’s regulation.
• Messenger RNA (mRNA) carries the genetic information coded in
the DNA from the nucleus to the cytosol. This information corresponds
to the primary amino acid sequence of the protein to be synthesized,
8
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Figure 1.3: Transcription of DNA
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transcribed from a specific genome region called gene.
Many eukaryotes genes have a large number of nucleotides, much more
than the corresponding complementary mRNA. After a careful exper-
imental analysis, it was possible to conclude that two types of regions
constitute most of the genes in eukaryotes cells. The first type of re-
gion is the one that codify the protein and are and the second type is
a DNA region that do not codify proteins, which are denominate ’in-
trons’. The mature mRNA, is constituted only by exons, and for that
reason is always smaller than the gene, concerning the chromosomal
DNA, as it also takes the introns.
• Transfer RNA (tRNA) is a hairpin shape RNA that reads the code
in the mRNA and carries the amino acid that will be used in the pro-
tein synthesis in the translation process.
• Ribosomal RNA (rRNA) is the catalytic component of a nucleo-
protein called ribosome. The ribosome serves as the location where the
protein synthesis takes place and it also carries the necessary enzymes
for completing the process.
• Regulatory RNAs are part of gene expression down-regulation by be-
ing complementary to a gene’s DNA or a part of a mRNA. For example
the RNA interference (RNAi) is a system in the cell that gets involved
in the control or regulation of the gene. Telling it in which moment it
needs to be activated and how strong the activation should be. As part
of this system the MicroRNAs (miRNA; 21-22 nt; found in eukaryotes)
block the mRNA from being translated, or accelerate its degradation
through an effector enzymatic complex responsible of breaking down
mRNA which the miRNA is complementary to [Matzke and Matzke,
2004, Wu and Belasco, 2008]. Small interfering RNAs (siRNA; 20-25
nt) are considered a RNAi that works in a similar way to miRNAs, often
produced by breakdown of viral RNA, and also by endogenous sources
[Vazquez et al., 2004, Watanabe et al., 2008]. Some researchers have
found that miRNAs and siRNAs can cause methylation of the genes
they target, decreasing or increasing their transcription [Sontheimer
and Carthew, 2005, Pushparaj et al., 2008, Doran, 2007].
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Some other types of regulatory RNAs have been reported, like CRISPR
RNAs, a regulatory system similar to RNA interference, found in prokary-
otes [Horvath and Barrangou, 2010], or the Piwi-interacting RNAs
(piRNA; 29-30 nt, found in animals) active in germline cells which
possible function is thought to be a defense against transposons and
play a role in gametogenesis [Horwich et al., 2007, Girard et al., 2006].
Also antisense RNAs are reported to be widespread, few of them as
a transcription activators [Wagner et al., 2002] and the others down-
regulate a gene, in some cases by binding to a mRNA and forming
double-stranded RNA that is enzymatically degraded [Gilbert, 2010].
Long non-coding RNAs have been reported too, which principal func-
tion is gene regulation in eukaryotes. [Amaral and Mattick, 2008, Heard
et al., 1999].
1.3.2 Translation
Translation is the process of converting mRNA into proteins. It takes place
in the cytosol on top of a ribosome. Cytosol contains amino acids, tRNA,
and ribosomes, which are needed for protein synthesis.
tRNA is essential to the translation process because each tRNA molecule
carries an amino acid to the ribosome. tRNA recognizes the code and binds
itself to the mRNA molecule by an anti-codon, a tRNA region that has three
complementary bases which function is recognize and bound to a specific
mRNA codon. In the step 1 of the translation, the starting codon (AUG) is
recognized by the tRNA and the tRNA binds to the mRNA and brings an
amino acid (methionine) with it.
The small ribosomal subunit in eukaryotes (40 S) is responsible of control-
ling base-pairing between the tRNA anticodon and each mRNA codon during
protein synthesis. In order to be able to scan successfully from the 5′ cap to
the start codon, the small ribosomal subunit needs to be able to overcome
intramolecular secondary structures that would, otherwise, block progress
along the RNA. Detailed studies in mammalian and fungal systems have
demonstrated that the inhibitory influence of stem-loop structures in the 5′
untranslated regions (5′ UTRs) of mRNAs is related to the stability of these
structures. RNA helicases are proteins that can disrupt stemloop structures
and hence, there is the expectation that proteins of this type should be ca-
pable of facilitating 40 S binding and scanning. Most RNA helicases contain
variations of a DEAD box motif along with six other highly conserved motif.
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Figure 1.4: An overview of ribosomal structure and mRNA translation.
[Source Steitz, 2008]
mRNA translation (Figure 1.4) is initiated with the binding of tRNAfmet to
the P site. An incoming tRNA is delivered to the A site in complex with elon-
gation factor (EF ) − Tu–GTP . Correct codon-anticodon pairing activates
the GTPase centre of the ribosome, which causes hydrolysis of GTP and
release of the aminoacyl end of the tRNA from EF − Tu. Binding of tRNA
also induces conformational changes in ribosomal (r)RNA that optimally ori-
entates the peptidyl-tRNA and aminoacyl-tRNA for the peptidyl-transferase
reaction to occur, which involves the transfer of the peptide chain onto the
A site tRNA. The ribosome must then shift in the 3′ mRNA direction so
that it can decode the next mRNA codon. Translocation of the tRNAs and
mRNA is facilitated by binding of the GTPase-EF-G, which causes the dea-
cylated tRNA at the P site to move to the E site, and the peptidyl-tRNA
at the A site to move to the P site upon GTP hydrolysis. The ribosome is
then ready for the next round of elongation. The deacylated tRNA in the
E site is released so that it can be bound the nex aminoacyl-tRNA to the
A site. Elongation ends when a stop codon is reached, which initiates the
termination reaction that releases the polypeptide [Steitz, 2008].
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1.4 Central dogma of molecular biology Ex-
ceptions.
Although RNAs have been considered for a long time as informative macro-
molecules that carry messages from the genome to the proteome, they are
becoming increasingly appreciated as regulatory macromolecules. [Lioliou
et al., 2010].
In 1970, Temin’s stunning finding of reverse transcriptase (RT) [Temin and
Mizutani, 1970] revolutionized our understanding of genome function, be-
cause it showed for first time the existence of a second flow of information,
from RNA to DNA, in sharp contrast with the central dogma that admitted
DNA to RNA as the only possible informational direction.
Exceptions to the central dogma include reverse transcriptases, enzymes that
synthesize DNA from RNA [Sciamanna et al., 2009] . Moreover, DNA is not
static and does more than serves as an inert source of information. Rather,
DNA is dynamic and modifiable. DNA modifications contribute to gene tran-
scription regulation, such as chromatin organization and remodeling, genomic
imprinting, DNA methylation, and other mechanisms. [Robinson, 2009].
Recent transcriptome analysis and different experimental approaches have
identified a surprisingly large number of non-coding RNAs (ncRNAs) in
eukaryotic cells. ncRNAs comprise microRNAs, anti-sense transcripts and
other Transcriptional Units containing a high density of stop codons and
lacking any extensive Open Reading Frame. As Central Dogma exception
they have been shown to regulate gene expression by novel mechanisms such
as RNA interference, gene co-suppression, gene silencing, imprinting and
DNA demethylation. [Costa, 2005].
It is widely known today that the DNA-RNA connection is bi-directional,
reverse transcription does exist. The old and discarded idea that even pro-
teins can carry genetic information came back, at least temporarily, with the
discovery of prions. Undoubtedly, there are biological functions which would
be difficult to explain without the existence of reverse information flow from
proteins back to nucleic acids, for example the immune response and the
formation of long term memory, both requiring de novo protein synthesis.
[Biro, 2004].
In conclusion relying on several sets of experimental results which indicated
13
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Figure 1.5: Molecular biology central dogma representation under their
exceptions. [Source Thieffry and Sarkar, 1998]
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that compounds other than DNA (e.g. DNA polymerase and aminoacyl-
tRNA synthetase) affect the result of transcription, Commoner replaced the
unidirectional flow of information prescribed by the Central Dogma with a
more complex scheme that explicitly includes feedback from proteins to DNA
and RNA (Figure 1.5). [Thieffry and Sarkar, 1998].
1.5 Gene expression control
The characteristics of organisms result largely from the dynamic interplay
between DNA or RNA and the regulatory apparatus. The gene expression
control is a fundamental process to bring the genome to life, and it pervades
most of biology, from cell proliferation and differentiation to development.
Recent technological advances are transforming our understanding of how
the DNA sequence of the genome is transcribed into its functional output
of RNA and protein. Researchers are uncovering new layers of complexity
on many levels, ranging from the mechanism by which genes are transcribed
into RNA to how genetic changes can give rise to disease. [Eccleston and
Skipper, 2009].
There are many forms to control the gene expression when a gene has to
be expressed into a functional protein. Those forms of control have been
associated to: Pre-transcriptional steps (DNA unpacking and transcription)
and post-transcriptional steps (alternative splicing, mRNA transport, mRNA
degradation, translation and post-translational protein modification)
1.5.1 Pre-transcriptional control
The eukaryotic DNA is packaged into chromatin, which is organized as DNA
segments wound around a protein core of histones call nucleosomes. The
chromatin structure is directly related to the control of gene expression be-
cause it may block RNA polymerase access to the promoter regions. RNA
Polymerases can be three different types: I, II and III in eukaryotes, where
RNA polymerase II (RNA Pol II) is part of the transcription mechanism of
all protein genes, and the other two polymerases I and III are part of the
transcription of the three rRNA genes (28S, 18S, and 5.8S), clustered as a
pre-rRNA gene in mammalian genomes, and the tRNA, 5S rRNA and the
U6 snRNA genes, respectively.
The combination of nucleosome positioning and dynamic modification of
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DNA and histones has a key role in gene regulation and guides develop-
ment and differentiation [Wang et al., 2008]. Chromatin states can influence
transcription process directly by altering the packaging of DNA to allow or
prevent access to DNA-binding proteins, or they can modify the nucleosome
surface to enhance or impede recruitment of effector protein complexes. Re-
cent advances suggest that this interplay between chromatin and transcrip-
tion is dynamic and more complex than previously appreciated, and there
is a growing recognition that systematic profiling of the epigenomes in mul-
tiple cell types and stages may be needed for understanding developmental
processes and disease states. [He et al., 2008].
Regulatory proteins bind to DNA either to block or to stimulate transcrip-
tion, modifying how the DNA interacts with RNA polymerases. Controlling
the expression of eukaryotic genes requires general and specific transcription
factors. The general transcription factors: TFIIA, TFIIB, TFIID, TFIIE,
TFIIF and TFIIH (TF stands for transcription factor and II for the RNA
Pol II), are required for transcription initiation facilitating the proper bind-
ing of RNA Pol II to the DNA [Lee and Young, 2000] (Figure 1.6); and the
specific transcription factors (e.g sigma factors in prokaryotes) increase tran-
scription in certain cells or in response to signals.
Methylation (the addition of -CH3) of DNA or histone proteins is associated
with the control of gene expression too. The addition of acetyl groups to
histone tails remodel the nucleosomes doing that DNA available for tran-
scription [Berg et al., 2006]. Clusters of methylated cytosine nucleotides
bind to a protein that prevents activators from binding to DNA. Methylated
histone proteins are associated with inactive regions of chromatin.
1.5.2 Post-transcriptional control
The post-transcriptional mechanisms are an important part of the regula-
tion of gene expression, making possible that the gene expression can be
controlled precisely, mostly by modulation of mRNA stability [Pautz et al.,
2006]. Post-transcriptional mechanisms of gene expression are intricate, and
their elucidation is essential for obtain full understanding of how gene ex-
pression is regulated, which is the interplay between these mechanisms, and
how their dysfunction is involving in numerous genetic disorders and cancer.
[Chen and Manley, 2009].
Post-transcriptional mechanisms usually involves: RNA interference, alter-
native splicing, RNA editing and mRNA degradation. RNA interference
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Figure 1.6: Assembly of the pre-initiation complex (PIC). TBP first
binds to the promoter and then recruits TFIIB to join TFIID (and TFIIA
if present). Before entering PIC, RNA Pol II and TFIIF are bound to-
gether, and recruited by TFIIB. Finally, RNA Pol II recruits TFIIE, which
further recruits TFIIH to complete the PIC assembly.
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involves the use of small RNA molecules. The enzyme Dicer chops double
stranded RNA into small pieces of RNA by means micro-RNAs bind to com-
plementary RNA to prevent translation and small interfering RNAs degrade
particular mRNAs before translation. [Lodish et al., 2007].
In a recent publication, Brookes and Pombo [2009] found that the regulation
of gene expression is essential for the generation of diverse cell types during
the development and the adaptation process to the environmental signals.
RNA Pol II transcribes genetic information and coordinates the recruitment
of accessory proteins that are responsible for the establishment of active chro-
matin states and transcript maturation. RNA Pol II is post-translationally
modified at active genes during transcription initiation, elongation and termi-
nation, and thereby recruits specific histone and RNA modifiers. RNA Pol
II complexes are also located at silent genes in promoter-proximal paused
configurations that provide dynamic transcriptional regulation downstream
from initiation. [Brookes and Pombo, 2009].
Genes that encode various RNAs are transcribed in the nucleus (although
some are transcribed in mitochondria) by RNA Pol I, II or III, been the
primary transcripts of theses genes in eukaryotes cells, virtually never the ma-
ture active species. These primary RNAs usually undergo post-transcriptional
processing: 5′ capping, 3′ polyadenylation, pre-mRNA splicing and in some
cases RNA editing (alternative splicing). The rate of translation of mature
mRNA depends of its concentration in the cytoplasm, which is determined by
the RNA quality control, mRNA transport, storage and degradation mecha-
nisms.
The splicing
Typically a pre-mRNA is a single strand composed by nucleotide’s sequences
called introns that will not be translated nor alternated with exons but will
be translated into a protein. Introns are spliced out of pre-mRNAs to pro-
duce the mature mRNA that will be translated. Mature mRNA molecules
have various half-lives depending on the gene and the tissue where they are
been expressed, and the amount of polypeptides produced from a particular
gene is influenced by the half-life of the mRNA molecules.
Maturation of mRNA transcripts requires sophisticated machineries to re-
move the introns and join the exons. This process known as ’splicing’ is
regulated by dedicated splicing factors and is a very significant source of
proteome complexity because alternative exon-assembly (alternative splic-
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ing) allows for a majority of genes to encode more than one protein.
Alternative splicing is a regulated mechanism and the product of a gene
will frequently vary from one tissue to the other, dictated by the balance of
splicing enhancer and repressor activities that are presented [Shi and Manley,
2007, Matter et al., 2002]. Recent data have shown that these factors contact
the RNA Pol II as well as transcription factors and chromatin remodeling
enzymes present inside the coding region of the gene [Allemand et al., 2008].
Splicing also responds to various signal transduction pathways activated by
external stimuli. Such stimuli are able to modify the activity of the splicing
factors or their expression level. Interestingly, the transcription’s activity
factor are also regulated by the same signal transduction pathways and even
more, there has been some speculation on the fact that transcriptional ma-
chinery could also be involved in splicing. This would only be truth if splicing
is initiated while the pre-mRNA is still under synthesis. Some authors also
suggest that chromatin could function as an RNA-binding matrix displaying
the immature transcripts to the spliceosomes. [Allemand et al., 2008].
Alternative splicing markedly affects human development, and the lack of
regulation and control over the splicing has improve many human diseases.
Although the mechanisms of alternative splicing have been studied exten-
sively, in the last few years has been discovered the diversity and complexity
of alternative splicing regulation by an intricate protein-RNA network. The
progress in such area still increases, and the research and study of individual
transcripts and through genome-wide approaches have provide a better pic-
ture of the mechanistic regulation of alternative pre-mRNA splicing. [Chen
and Manley, 2009].
In addition, a vast number of alternative splicing events have been identified,
adding to the complexity and ubiquitous expression of the human transcrip-
tome [Tress et al., 2007, Wang et al., 2008]. This plasticity at the RNA level is
even further accentuated by the presence of an immense number of inhibitory
RNAs [Yelin et al., 2003, Katayama et al., 2005] and the recent discovery that
tens of thousands of binding sites are present across the genome, as shown
by genome-wide profiles of the DNA binding of mammalian transcription
factors. [Robertson et al., 2007, Ponten et al., 2009].
Spliceosome
The spliceosome is a ribonucleoprotein machine which main function is to re-
move introns from pre-mRNA in a two-step reaction. Warkocki et al. [2009]
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investigated the catalytic steps of splicing and they established an in vitro
splicing complementation system. This system allows future mechanistic
analyses of spliceosome activation and catalysis.
The spliceosome assembly Is carried out by a sequential formation of the A,
B and C complexes, from the ensemble of two previous complexes known as
E and H (Figure 1.7). Different substrate-specific proteins are part of H (col-
ored in orange - 1.7) and they are not directly involved in the spliceosome
assembly, but their bound proteins might influence the ability to progress
to the E complex, the earliest complex committed to the splicing pathway.
Although they have not traditionally been thought to contain splicing fac-
tors, the H complex formed on the c-src N1 exon contains U1 small nuclear
ribonucleoprotein (snRNP). Within the E complex, all the consensus splice-
site elements are recognized: the 5′ splice site (indicated as GU) is recognized
by U1 snRNP, the branch point (BP; pink circle) by SF1 and the polypyrim-
idine tract (PPT; pink rectangle) and 3′ splice site (AG) by U2AF65 and
U2AF35, respectively (blue ellipses 65 and 35). E complexes have mainly
been characterized as cross-intron complexes (left), but in multi-exon pre-
mRNAs they form initially across exons (i.e. exon definition; right). Sta-
bilizing interactions between factors bound to the 5′ and 3′ splice sites are
indicated schematically by the double-headed red arrows. Such interactions
might be mediated by SR proteins, which can bind to exon splicing enhancers
(ESE), or formin-binding protein (FBP). Cross-exon interactions must be re-
placed by cross-intron interactions in the later splicing complexes (B and C)
for splicing to occur. [Spellman and Smith, 2006].
RNA binding proteins (RBP)
The processes of RNA splicing, transport, capping, editing, and polyadeny-
lation depend mainly on protein factors that recognize the pre-mRNA and
assemble the appropriate pre-mRNA processing complexes. Many different
protein factors that guide pre-mRNA modification pathways are composed
of a limited number of conserved, modular RNA-binding domains. Of these,
the RNA recognition motif (RRM) domain is by far the most abundant type
of eukaryotic RNA-binding motif. The most conserved RRM signature se-
quence is an eight-residue motif called ribonucleoprotein 1 (RNP1). Besides
the protein association with RNA, the protein-protein interactions are fun-
damental for extracting and obtaining the catalytic components to sites of
RNA modification and to coordinate pre-mRNA processing with other cel-
lular pathways. Further more, common protein interaction domains, such
as SH2, SH3, and WW motifs, are rarely observed in pre-mRNA processing
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Figure 1.7: Spliceosome assembly: H and E complexes
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factors [Shatkin and Manley, 2000, Zhou et al., 2002], where the ability to
interact between each other probably relies the sequences previously thought
to be involved in RNA binding. [Kielkopf et al., 2004].
Several RNA-binding proteins are characterized by having a modular struc-
ture and being composed of multiple repeats of few basic domains, which
are arranged in different ways in order to satisfy their many and various
functional requirements. Lately, researches have been investigating the co-
operation between different modules that allows regulating the RNA-binding
specificity and the biological activity of these proteins. They have also in-
vestigated how multiple modules cooperate with enzymatic domains to reg-
ulate the catalytic activity of enzymes that act on RNA. And so the results
show how multiple modules define the fundamental structural unit that is
responsible for biological function [Lunde et al., 2007], at least for several
RNA-binding proteins.
RNA-binding proteins (RBPs) perform many essential functions in the post-
transcriptional control of gene expression. Play essential functions in all
post-transcriptional regulatory processes, including RNA processing, cellular
localization, translation and mRNA decay. These proteins recognize RNA by
using relatively few RNA-binding modules that combine to create versatile
macromolecular binding surfaces to define their specificity [Auweter et al.,
2006, Lunde et al., 2007, Chen and Varani, 2005].
RNA binding proteins (RBP) classes
At least nine families of RNA binding proteins have been identified using
sequence-based analyses of RNA binding proteins, together with functional
characterization of mutations that affect the specificity or affinity of RNA
binding. But the number of experimentally determined structures for RNA-
protein complexes is still relatively small and heavily biased (ribosomal pro-
teins represent 50% of all RNA binding proteins in the Protein Data Bank
[PDB]). However, some computational analyses of RNA-protein complexes
have generated databases of RNA-protein contacts and provided valuable
insights into the biophysical basis of interaction patterns between ribonu-
cleotides and amino acids. [Terribilini et al., 2006].
Polypyrimidine-tract-binding protein
Polypyrimidine-tract-binding protein (PTB) is a repressive regulator of al-
ternative splicing. Splicing decisions are usually the result of multiple an-
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tagonistic and synergistic influences of regulatory proteins. Activators of the
serine/arginine-rich (SR) protein family bind to splicing enhancers and con-
sist of RNA-binding domains and ’RS’ domains (enriched in Arg-Ser dipep-
tides) that contact other splicing factors and RNA. Repressor proteins such
as PTB typically bind to splicing silencers and have RNAbinding domains,
but lack RS domains. Most regulators seem to act at an early stage in the
pathway of spliceosome assembly (Figure 1.7).
Although spliceosomes form across introns, in multi-exon pre-mRNAs, the
early pre-spliceosomal ’E’ and ’A’ complexes (Figure 1.7) initially form coop-
eratively across exons in a process termed ’exon definition’; thus, regulators
could influence the formation of cross-exon or cross-intron complexes. SR
proteins are prime candidates to mediate cross-talk between 30 and 50 splice
sites, but the interactions network in exon definition is not well defined. The
recent work from the Valcarcel (www.crg.es) and Black (www.hhmi.ucla.edu)
laboratories show that the splicing repressor PTB targets the interactions in-
volved in exon and intron definition. [Spellman and Smith, 2006].
U2AF
During pre-mRNA splicing, U2AF65 (an heterodimeric splicing factor U2
snRNP auxiliary factor -U2AF65-) and some other important factors are re-
sponsible for making easy the sequential association between small nuclear
RNP particles (snRNPs), including U1, U2, U4, U5, and U6 snRNPs, with
the borders of intervening pre-mRNA sequences [Brow, 2002]. Following as-
sembly of the functional spliceosome, the intron is excised as a branched
lariat by two catalytic steps, and adjacent exons are joined together to form
the spliced mRNA.
U2AF65 was identified as a factor that binds to pre-mRNA consensus se-
quences at the 3′ splice site (3’ SS), and is required for stable association of
the U2 snRNP core spliceosome particle with the pre-mRNA branch point
sequence (BPS) during the first ATP-dependent step of the splicing pro-
cess (Complex A) [Ruskin et al., 1988, Zamore and Green, 1989]. Soon,
finding that both subunits are heavily needed in Drosophila melanogaster,
Caenorhabditis elegans and Schizosaccharomyces pombe, the U2AF65 in vitro
proved to be very important.
Because U2AF65 commits the pre-mRNA to the first critical ATP-dependent
step of splicing, its binding is often regulated during alternative splicing.
In humans, the products of five U2AF35-like open reading frames and the
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single U2AF65 subunit may form distinct heterodimers with different func-
tional activities. In addition to U2AF65, other non-snRNP protein factors
are required for building up Complex A, including Splicing Factor 1 (SF1)
and Splicing Factor 3b (SF3b), a multisubunit component of the U2 snRNP.
[Kielkopf et al., 2004].
1.6 RBPs immunoprecipitation: PTB and U2AF65
The RBPs U2AF65 and PTB as was said above are part of the spliceosome
and they have been studied by Gama-Carvalho et al. [2006], using RIP-Chip
technology. This experiment will be described in the next paragraphs, since
we applied the methodologies presented in this document to those data ob-
tained by Gama-Carvalho et al. [2006] using RIP-Chip technology.
HeLa cells were used by Gama-Carvalho et al. [2006] as a eukaryotic type
cell for the detection of the mRNA pools associated with U2AF65 and PTB
RBPs during the post-transcriptional gene expression control. In this ex-
periment (see Figure 1.8) an adherent HeLa cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM), 10% fetal calf serum (FCS) and peni-
cillin/streptomycin.
For the microarray experiments two different samples were prepared, an In-
put sample with the total mRNAs and immunoprecipitated sample (IP) for
a mRNA pool associated to a specific RBP (PTB or U2AF65).
The Input sample corresponds to total RNA isolated from the HeLa cell
lysate that was used as the starting point for the immunoprecipitation assay.
[Gama-Carvalho et al., 2006]
The IP sample was obtained by the immunoprecipitation of PTB or U2AF65-
associated mRNAs performed over pre-cleared HeLa cell lysate. First, im-
mune complexes were obtained by addition of a specific monoclonal antibody
(Bb7 anti-PTB mAb or anti-U2AF65 MC3) over the pre-cleared HeLa cell
lysate. Second, the immune complexes precipitation was made with a slurry
with 50% of protein A/protein G agarose beads blocked with tRNA and
RNAse free bovine serum albumin, followed by washes performed with lysis
buffer. [Gama-Carvalho et al., 2006]
Complexes bounded to the beads were eluted with TES buffer (10 mmol/l
Tris, 0.5 mol/l EDTA,0.5% SDS [pH 8.0]) after heating at 65◦C for 10 min-
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Figure 1.8: Immunoprecipitation of mRNAs bound to RBPs PTB and
U2AF65. Hibridization with GeneChip R© Human Genome U133 Plus 2.0
microarrays.
utes and were Trizol extracted for posterior mRNA analysis. RNAs from the
Input and IP samples were polyadenilated, reverse transcribed, end tagged
and PCR amplified. Resulting cDNAs from Input and immunoprecipitated
(IP) samples for microarray hybridization were labeled and hybridized to
Affymetrix GeneChip R© Human Genome U133 Plus 2.0 Arrays (Affymetric,
Inc., Santa Clara, CA, USA), as was described by Gama-Carvalho et al.
[2006].
A total of three independent immunoprecipitation experiments for U2AF65
and two for PTB were performed (Input and IP sample pairs, for each RBP),
corresponding to 10 microarray hybridization datasets overall.
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1.7 Microarray technology
Given that microarray hybridization is an important part of the RIP-Chip
methology applied by Gama-Carvalho et al. [2006], which results correspond
to the data sets used in this thesis, this section presents a short overview of
the microarray technology.
Microarray technology is based on the parallel hybridization of complemen-
tary nucleotide strands (DNA or RNA) with a genomic or transcriptomic
samples, that allows to detect the expression of hundred of thousands of
genes at the same time [Schena, 1996]. Microarrays consist of thousands of
DNA molecules named probes (representing different genes) that are gridded
and immobilized onto a support such as nylon membrane, glass or silicon.
Each position of the microarray grid is known as spot or cell depending on
the technology used and corresponds to a specific gene or transcript.
The detection of the expression levels of all genes in cells taken from a cell
culture (tissue sample, cell line culture, microorgaminsm culture, etc.) using
microarrays is made by isolating the total mRNA (cell trascriptome at given
condition). cDNA fluorescently or radioactively labelled is then prepared
from the isolated mRNA pool (target molecules) and hybridized to the mi-
croarray. Afterwards, the unhybridized cDNA targets are washed away and
the signals of the hybridized cDNAs are quantified by measuring the fluores-
cence or radioactive signal of each spot or cell.
The measure of the signal of the hybridized cDNA targets is proportional to
the amount of isolated mRNA. The relative abundance of hybridized targets
on a defined array spot can be determined, allowing to compare in parallel
the transcription level of several thousands of different genes from one sample
to other samples in different experimental conditions.
Different array types have been designed, which differ by the density (spots
per square centimeter) of the array and more important, by the type of probes
that are immobilized (synthetic oligonucleotides or cDNA ). There are two
basic sources for DNA probes on a microarray that define the microarray
type. First, microarrays where each probe (oligonucleotides between 20 to
80 mer long) is individually synthesized in situ on a rigid surface (in general
glass) using the photolithographic methods, one of them developed by Fodor
et al. [1993] and initially commercialized by Affymetrix (described next sec-
tion).
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Second, microarrays where each probe is pre-synthesized or PCR amplified
(usually 25-5000 mer long) and immobilized to a solid surface such as glass
(or nylon) using a robot spotting, methodology proposed more than 30 years
ago by Ed Southern and popularized by the Patrick Brown laboratory at
Stanford University. The Stanford methodology has been extensively used
by the academic research laboratories because it is more affordable in the
sense that it allows flexible microarrays design and the equipment is cheaper
in relationship with the in situ synthesis microarrays. The last ones require
more sophisticated and expensive robotic equipment, but allows high density
microarrays (hundred of thousand of spots per array) in contrast to 200 to
10,000 spots allowed by the Stanford arrays.
1.8 Affymetrix microarrays
Affymetrix microarrays are produced using a combination of photolithogra-
phy and combinatorial chemistry. In each array are synthesized up to 1.3
million different probes. Each probe (25 mer oligonucleotide) is located in
a specific area within the array, called probe cell and each cell may contain
hundreds of thousands or even millions of copies of given oligonucleotide.
[Affymetrix, 2009]
The probes correspond to 11 up to 20 unique regions that allow the specific
hybridization of each one of the complementary sequences (genes, RNAs,
expressed sequence tags [ESTs]) aimed to be detected in a sample. These
probes are named perfect mach (PM). For each PM in the array an identical
probe is included which differs only in the 13th position, where the original
nucleotide at the PM is substituted by its complementary nucleotide (A
by T or C by G, or vice versa) (see Figure 1.9). These probes are called
mismatch (MM) and are used as a reference for later background correction.
[Affymetrix, 2009].
Figure 1.10 shows how the Affymetrix arrays are made through a series of
cycles where all the probes are synthesized simultaneously on the array sur-
face. Initially, the glass substrate is coated with linkers containing photo
labile protecting groups. Then a photolithographic mask is applied expos-
ing selected glass areas (probes cells) to the ultraviolet light. This process
removes the protective groups and allows the selective addition of a specific
phosphoramidite nucleoside on the exposed sites. Four cycles using 4 dif-
ferent photolithographic masks, one for each nucleotide (ATGC) are made
for synthesizing the first probe position of every probe included in the array.
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Figure 1.9: Affymetrix probe selection. 11 up to 20 unique region in the
genomic target (gene, RNA, EST) are selected and used as a template of
the perfect mach probes and the mismatch probe during the array design.
Thus cycles are repeated until the 25 nucleotides of each probe are synthe-
sized [Affymetrix, 2009].
The Affymetrix array used by Gama-Carvalho et al. [2006] was the GeneChip R©
Human Genome U133 Plus 2.0. This array provides complete coverage of the
Human Genome, allowing the analysis of more than 38,500 well-characterized
human genes and 47,000 transcripts on a single array, using more than 54,000
probe sets and more than 1.2 million probes. [Affymetrix, 2007]
28
1.8. Affymetrix microarrays
Figure 1.10: Synthesis of oligonucleotides on GeneChip R© mi-
croarrays, based on the concept of photolithography. (Source:
http://www.dkfz.de/gpcf/24.html)
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Chapter 2
RIP-Chip experiment data
analysis
2.1 Introduction
RNA Binding Proteins (RBP) are an important part of the gene expression
regulation. They are involved in the intron elimination and in the synthesis
of different proteins from a single gene through alternative splicing. It has
also been established that one of the gene control expression level mecha-
nisms of the cells after transcription is binding some RBPs to specific sites of
the transcript sequences. This mechanism can alter the speed of transcript
concentration decay, depending of the RBPs affinity and the cells environ-
ment, controlling the protein production and giving the cell the ability to
change transcript levels in a fast way. [Mata et al., 2005].
In this context, it has been proved that some proteins bind differentially to
mature mRNAs and travel with them to the cytoplasm, contributing to the
translation level control of some genes [Gama-Carvalho et al., 2001]. That
is the case of the U2 small ribonucleoprotein (U2AF65) which is an auxiliary
factor in the spliceosome assembly occurred inside the nucleus [Zamore and
Green, 1989, Zamore et al., 1992], in charge of recognizing the AG dinu-
cleotide at the 3′ splice site [Merendino et al., 1999, Wu et al., 1999, Zorio
and Blumenthal, 1999]; and the case of the Polypyrimidine Tract Binding
Protein (PTB), component of the spliceosome [Garc´ıa-Blanco et al., 1989],
involved in the alternative splicing regulation, suppressing the inclusion of
alternative exons [Black, 2003]. The U2AF65 and the PTB have been re-
ported to bind differentially to mature mRNAs and travel with them to the
cytoplasm, helping in the translation control level of certain groups of genes
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and other cellular functions . [Gama-Carvalho et al., 2001]
The high throughput molecular technique known as RNA immunoprecipi-
tation and hybridization on Chip (RIP-Chip) [Baroni et al., 2008, Keene
et al., 2006], has been used for the simultaneous determination of the mR-
NAs that are binding to a specific RBP. Basically this technique consists of
the immunoprecipitation of the a complex mRNA-RBP using RBP antibody,
followed by the mRNA purification and later microarray hybridization. The
analysis of the data obtained in this way is the aim of the present work.
2.2 The Gama-Carvalho et al. RIP-Chip ex-
periment data analysis
The hybridization of the labeled-cDNA (obtained from the immunoprecipita-
ted mRNAs or the Input samples) to an Affymetrix array is followed by the
acquisition of fluorescence signals emitted by the labeled-cDNA hybridized,
using laser scanning confocal microscopy. Typically the Affymetrix scanner
produces an image that is stored as a file with the extension .dat.
The Affymetrix GCOS (GeneChip R© Operating Software) suite computes
cell intensity data from the image file, and a .cel file is obtained. It contains
a single intensity value for each probe cell delineated by the grid (calculated
by the Cell Analysis algorithm). [Affymetrix, 2004]
As it was mentioned above Gama-Carvalho et al. [2006] ran a total of three
independent immunoprecipitation experiments for U2AF65 and two for PTB
(Input and IP sample pairs for each RBP), corresponding to a total of 10
microarray hybridization datasets that were laser scanned and processed (10
different .cel files), as is shown in Table 2.1.
The Affymetrix GCOS suite could be used to analyze the cell intensity data
[Affymetrix, 2004], as well as many other tools like dChip [Li and Wong,
2001] or Bioconductor – R library specialized in microarray data analysis.
[Gentleman et al., 2004]
In general these tools cover two main steps in the Affymetrix data analysis,
low level analysis and gene selection. The low level analysis itself has different
steps too: microarray quality assessment, background correction, normaliza-
tion and summarization. Gene selection, may include different statistical
and non-statistical methodologies. In the case of the RIP-Chip experiments,
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Table 2.1: Gama-Carvalho et al. [2006] experiment .cel files. Input sam-
ples correspond to the wild sample and IP correspond to the immunopre-
cipitated sample
Sample Experiment type U2AF65 PTB
1 Input AB2004021301.cel AB2004031115.cel
IP AB2004021302.cel AB2004031116.cel
2 Input AB2004021303.cel AB2004031117.cel
IP AB2004021304.cel AB2004031118.cel
3 Input AB2004021305.cel
IP AB2004021306.cel
given the lab methodology applied, this step is named enriched gene selec-
tion. The next sections will give a short explanation of these general steps
and some them will by applied to the Gama-Carvalho et al. [2006] data.
2.2.1 Low level analysis
Quality assessment
Exploratory data analysis is an important starting point during the microar-
ray data analysis, being the quality assessment (QA) critical for obtaining
highly reproducible results.
First step in general is to determine if any anomalies exist by taking a look
at the image plots of the probe-level data (PM and MM). The idea is to look
for spatial artifacts or other nonhomogeneous patterns in the image plots.
The image plots across an experiment array set may help to see whether one
or more arrays might appear abnormal or potentially defective, when they
display spatial artifacts (for example scratches) or appear lighter or darker
than the others.
log2 image plots
The Bioconductor libraries of R [Gentleman et al., 2004] were used for gen-
erating the log2 image plots for the 4 PTB and 6 U2AF
65 arrays of the
Gama-Carvalho et al. [2006] data. The ReadAffy() command of the Bio-
conductor Affy library allows to read the .cel files that contain the intensity
33
Chapter 2. RIP-Chip experiment data analysis
data for each probe along with other important values, and an affy object
is generated for further analysis. The R code is shown in appendix A.1.1.
[Gentleman et al., 2004]
The log2 image plots in Figure 2.1 (obtained using the function image() –
R code appendix A.1.1), appear similar to each other displaying no obvious
anomalies, neither for the PTB arrays nor for U2AF65 arrays of the RIP-Chip
Gama-Carvalho et al. [2006] data.
Boxplots and density plots
The boxplots and density plots of the probe-level data allow to determine
the existence of potentially defective arrays too. For example, boxplots that
stand out from the others, that show displaced boxes (interquartile ranges,
IQR) or different ranges, or in the case of the density plots, densities that are
removed from the others, that display bimodalities, show uniquely different
shapes or other abnormalities. [Bolstad et al., 2005]
In the case of PTB and U2AF65 RIP-Chip experiments both Figures 2.2 and
2.3 (R code is shown in appendix A.1.1) show that there are no potential
defective arrays in Gama-Carvalho et al. [2006] data. Density plots showed
a similar and typical curve shape for Affymetrix arrays for both experiments
(PTB and U2AF65), not displaying any bimodalities and existing a signifi-
cant overlap among the individual density plots (Figure 2.3). The probe-level
data boxplots (Figure 2.2) do not show any array significantly standing out
from the others. These results suggest good quality on the arrays.
MA plots
MA plot is another exploratory plot for Affymetrix arrays quality assess-
ment. M values represent, for each gene, the difference of the log intensities
of a certain probe between two arrays. The M values are plotted against the
average (denoted by A) of the same log intensities. When more than two
arrays are compared, a reference array is created by taking the probe wise
medians [Bolstad et al., 2005] across all arrays, and then each array in the
experiment may be plotted versus the reference array.
Quality problems are evident if there is a high variability of the M values
in one or more arrays relative to the others [Bolstad et al., 2005]. Another
evidence of quality problem is the case where the MA-plot shows that the
loess smoother oscillates wildly. MA plots of PTB and U2AF65 RIP-Chip
34
2.2. The Gama-Carvalho et al. RIP-Chip experiment data analysis
(a) PTB arrays
(b) U2AF65 arrays
Figure 2.1: Image plots of perfect match (PM) and mismatch (MM)
probe intensities (log2) for PTB and U2AF
65 RIP-Chips arrays of the
Gama-Carvalho et al. [2006] data. Input correspond to the wild samples
and IP to the immunoprecipitated samples.
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(a) PTB arrays (b) U2AF65 arrays
Figure 2.2: Boxplots of PTB and U2AF65 RIP-Chips arrays of the
Gama-Carvalho et al. [2006] data. Input correspond to the wild samples
and IP to the immunoprecipitated samples.
(a) PTB arrays (b) U2AF65 arrays
Figure 2.3: Density plots of PTB and U2AF65 RIP-Chips arrays of the
Gama-Carvalho et al. [2006] data. Input correspond to the wild samples
and IP to the immunoprecipitated samples.
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arrays (Figures 2.4 (a) and (b), respectively) where obtained using the R
code shown in the appendix A.1.1 and they did not show evidence for the
anomalies mentioned before.
RNA degradation plots
Another Affymetrix Chips quality test is the RNA degradation evaluation.
RNA degradation is normally present during the hybridization experiments
and is usually major in the 5’ end of the RNA. Therefore, if the specific tran-
script probes are numbered sequentially from the 5’ to 3’ end of the RNA
targeted, PM probes intensities at 5’ end may be systematically minor than
the 3’ end probes intensities when the RNA degradation is high. In general,
following 5’→ 3’ orientation, for the middle probe positions the degradation
rate is constant and higher than zero, whereas for the ends the degradation
rate may not constant assuming small values. [Alvord et al., 2007]
Figure 2.5 produced by the R code shown in appendix A.1.1 shows the RNA
degradation for PTB and U2AF65 RIP-Chip arrays and their slopes are sum-
marized in the Table 2.2. The curves have the expected behavior and are
similar for each RIP-Chip experiment, PTB and U2AF65 (Figure 2.5). Slopes
are close to 1, pointing out the RNA degradation trend to be moderate and
the curves look reasonably parallels. Is important to say that each array
type has its own characteristic degradation slope and there is no threshold
for determining a bad array, reason because some authors consider that RNA
degradation plots have narrowed utility. [Bolstad et al., 2005].
Probe-level models
Probe-level models (PLM) fitted to probe-intensity data [Bolstad, 2011], have
been used in determining the quality of Affymetrix chips, providing param-
eter estimates for probe sets (genes) and chips. In general, the PLM proce-
dures are powerful tools that allow to make visible the effects not appearing
in other images or to detect artifacts that might otherwise be missed com-
pletely. [Bolstad, 2011].
affyPLM Bioconductor library provides different alternatives for fitting PLM
through the function fitPLM [Bolstad, 2011]. For checking the Gama-Carvalho
et al. [2006] RIP-Chip arrays quality, default PLM options were chosen that
use the RMA and Quantile Normalization for background correction and nor-
malization, respectively, frequently applied to this kind of analysis. [Bolstad
et al., 2005, Bolstad, 2011]
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(a) PTB arrays
(b) U2AF65 arrays
Figure 2.4: MA plots of each PTB and U2AF65 RIP-Chips arrays of
the Gama-Carvalho et al. [2006] data versus the synthetic (median) array,
centered at zero. Input correspond to the wild samples and IP to the
immunoprecipitated samples.
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(a) PTB arrays (b) U2AF65 arrays
Figure 2.5: RNA degredation plos of each PTB and U2AF65 RIP-Chips
arrays of the Gama-Carvalho et al. [2006] data versus the synthetic (me-
dian) array, centered at zero. Input correspond to the wild samples and
IP to the immunoprecipitated samples.
The fitPLM function of the affyPLM Bioconductor library, fitting a specified
robust linear model to the probe level data which fits a specified robust linear
model to the probe level data [Bolstad, 2011], returns the following linear
PLM model (equation 2.1) for the background correction and probe-level
data normalization [Irizarry et al., 2003b]:
log2 Sgij = θgi + ϕgj + εgij (2.1)
where, Sgij is the PM (perfect match) signal value for the j-th probe on the
g-th gene on the i-th array; θgi is the expression level for the g-th gene on the
i-th array; ϕgj is the j-th probe on the g-th gene; and εgij is the measurement
error. [Irizarry et al., 2003b].
The fitPLM function produces an object containing information regarding the
parameter estimates, standard errors, weights, residuals and signed residuals
[Bolstad et al., 2005, Bolstad, 2011].
Figures 2.6, 2.7 and 2.8 (generated by the R code shown in the appendix
A.1.1), show the array pseudo-images of the residuals, weights, and signed
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(a) PTB arrays
(b) U2AF65 arrays
Figure 2.6: Chip pseudo-images base on residuals of the PLM fit ar-
rays PTB and U2AF65 of the Gama-Carvalho et al. [2006] data. Input
correspond to the wild samples and IP immunoprecipitated samples.
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Table 2.2: Summary of the slopes for the RNA degradation plots for
PTB and U2AF65 RIP-Chip experiments
PTB RIP-Chip arrays
Input 1 IP 1 Input 2 IP 2
Slope 1.030000 0.7500 0.80300 1.01000
p-value 0.000173 0.0092 0.00598 0.00172
U2AF65 RIP-Chip arrays
Input 1 IP 1 Input 2 IP 2 Input 3 IP 3
Slope 1.2100000 1.93000000 1.030000 1.400000 0.70700 1.280000
p-value 0.0000715 0.00000075 0.000346 0.0000174 0.00875 0.000235
residuals based on PLM fit on PTB and U2AF65 RIP-Chip data. Figure 2.6
corresponds to the PLM Residuals plots, where the negative residuals are
darker (blue in color plots) and positive residuals lighter (red in color plots)
[Bolstad et al., 2005]. Both positive and negative residuals must be homoge-
neously spread out across the pseudo-images, as it is in general for the PTB
microarrays. This behavior is not so evident in the U2AF65 pseudo images,
where one can find some non-homogeneous areas, however it is not enough
to consider these microarrays problematic.
The PLM Weights plot (Figure 2.7) obtained from the robust regression pro-
cedure use topographical coloring in the pseudo-images. Dark areas (green in
color plots) represent low weights, corresponding to mis-performing probes
associated with outliers; and light areas indicate high weights. No apparent
spatial artifacts are present in the PTB and U2AF65 RIP-Chip plots, how-
ever the U2AF65 plot shows a few non-significant homogeneous areas but less
than the residuals plots (Figure 2.6, b)
The PLM Signed Residuals pseudo-images (Figure 2.8), show the signs of
the residuals, either -1 or +1 depending on whether the residual is positive
or negative [Bolstad et al., 2005]. No apparent spatial artifacts are present
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(a) PTB arrays
(b) U2AF65 arrays
Figure 2.7: Chip pseudo-images base on weights of the PLM fit arrays
PTB and U2AF65 of the Gama-Carvalho et al. [2006] data. Input corre-
spond to the wild samples and IP immunoprecipitated samples.
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(a) PTB arrays
(b) U2AF65 arrays
Figure 2.8: Chip pseudo-images base on signed residuals of the PLM fit
arrays PTB and U2AF65 of the Gama-Carvalho et al. [2006] data. Input
correspond to the wild samples and IP immunoprecipitated samples.
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in PTB and U2AF65 RIP-Chip plots, although U2AF65 plots show similar
behavior than in the other PLM plots, but not significant enough to consider
to remove some of the microarray datasets for further analysis.
Following the fitting of a PLM, it is possible derivate other useful array qual-
ity statistics like the Relative Log Expression (RLE) plots (Figure 2.9) or
Normalized Unscaled Standard Error Plot (NUSE).
Relative Log Expression (RLE) plots
RLE first estimates, from the PLM fit, the log scale of expression θˆgi for each
gene g on each array i, and then the median value across arrays for each gene
g, m(g), is computed. The RLE is defined as follow:
RLEgi = θˆgi −m(g) (2.2)
These values are then displayed with a boxplot for each array. In a com-
mon gene expression experiment it is assumed that the majority of genes are
not changing expression between the samples (for example, wild sample vs.
treated sample comparison). The RLE boxplot should be centered at 0 and
have small spread. The presence of a box that has relatively high spread
and is not centered around 0, may indicate an array with quality problems
[Bolstad et al., 2005].
Figure 2.9 (generated by R code presented in appendix A.1.1), shows that
the RLE plots for PTB and U2AF65 RIP-Chip arrays are centered around 0,
with similar box sizes (i.e. IQRs), indicating no quality control problems.
Normalized Unscaled Standard Error (NUSE) plots
Normalized unscaled standard error (NUSE) plot is another graphical tool
where the standard error of the estimates SE (θˆgi) are obtained for each gene g
on each array i from the PLM fit. Since the variability may differ considerably
among genes, the standard errors of the estimates are standardized as they
are divided by the median of the standard errors across arrays, turning the
NUSE median equal to 1 for each gene (equation 2.3).
NUSEgi =
SE(θˆgi)
medi′=1,...,I{SE(θˆgi′)}
(2.3)
If some NUSE medians are high or if there are boxes with higher IQRs rela-
tive to the others, it may indicate problems with some arrays. NUSE values
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(a) PTB arrays (b) U2AF65 arrays
Figure 2.9: Relative Log Expression (RLE) Plot of the PLM fit arrays
PTB and U2AF65 of the Gama-Carvalho et al. [2006] data. Input corre-
spond to the wild sample and IP immunoprecipitated samples
are calculated only within a data set; therefore these values are not compa-
rable across data sets [Bolstad et al., 2005].
It appears that the NUSE boxplots in Figure 2.10 are reasonably centered
around the median 1, with relatively equal box sizes. Most of them do not
seem to present any quality -control problems, but is evident (Figure 2.10)
that the Input 1 from PTB microarray and the IP 3 from U2AF65 microarray
are slightly different from the others. Both show high values of NUSE me-
dians and boxes that have slightly more spread relative to the others, which
could be a sign of bad quality.
Other quality controls may be applied to Affymetrix microarrays, but in
general all control procedures serve as an indication wether the microarrays
quality is good, or if one or more microarray data sets should be excluded
in order to have more confident final results. There is no clear definition
on how many of these procedures must indicate a good quality microarray
data set, but some authors consider a poor quality microarray if it fails in
two or more of theses procedures [Alvord et al., 2007]. For the PTB and
U2AF65 RIP-Chip microarrays the last criteria was taken and all the chips
were considered to have good quality and, therefore, all microarrays were
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(a) PTB arrays (b) U2AF65 arrays
Figure 2.10: Normalized unscaled standard error (NUSE) plot for the
PLM fit arrays PTB and U2AF65 of the Gama-Carvalho et al. [2006] data.
Input correspond to the wild samples and IP to the immunoprecipitated
samples.
used in further analysis.
After quality assessment it is necessary to obtain final expression values for
each gene in each condition, as the observed intensities need to be adjusted
to give accurate measurements of specific hybridization. This process usually
involves three steps: background correction, normalization and summariza-
tion. [Alvord et al., 2007].
Background correction
Background correction is essential because the microarray raw intensities
must be adjusted to remove the influence of the background signal, which
may be the result of nonspecific hybridization, auto-fluorescence from the
slides, noise in the optical detection system and other reasons.
Different methodologies have been developed to perform this step. For ex-
ample, the MAS 5.0 algorithm [Affymetrix, 2009] calculates the signal as the
anti-log of a robust average (Tukey biweight) of the values:
log(PMij − IMij), j = 1, ..., J (2.4)
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where j is the probe number in the microarray i.
Although the mismatch (MM) probes are designed by Affymetrix to have
into account the non-specific hybridization and are allowed to correct the
perfect match (PM) signal, there is a large proportion of MM probes with
higher signal than the corresponding PM probe. Ideal Mismatch (IM) (equa-
tion 2.4) is used for dealing with possible negative numbers and is defined
as a quantity equal to MM when MM<PM, but adjusted to be less than
PM when MM>PM, which occurs in near of 30% of all MM. [Irizarry et al.,
2003b].
Li and Wong [2001] proposed a different approach which is used in their
dChip software package [Li and Wong, 2003]. They proposed that the dif-
ferent probes in a probe set might have different affinities for the same gene,
behavior that should remain constant across arrays (after normalization) and
therefore the affinities can be modeled for a set of arrays. They proposed the
following model:
PMij −MMij = θi.φj + εij (2.5)
In equation 2.5 [Li and Wong, 2001] the authors assume that the probe
affinities (φj) influence the final signal in a multiplicative manner, and are
constant across the arrays in the experiment. Therefore, fitting the model
using multiple arrays allows to obtain θi for each array i, giving a summary
statistic for the probe set and detecting probes that do not have a good fit
to the model and may be defective [Li and Wong, 2001]. Some authors have
reported that the Li and Wong [2001] model has strong mean variance de-
pendence. [Irizarry et al., 2003b].
Another probe affinity modeling approach is the robust multichip average
(RMA) [Irizarry et al., 2003b]. This method has been implemented in the
library affy of Bioconductor [Gentleman et al., 2004] and is one of the most
used for background correction and normalization of Affymetrix microarrays
data sets. RMA is different from other methods since it uses only the PM
probe intensities on each array, because of the high proportion of MM probes
that have higher intensities than the corresponding PM probe. RMA is
an additive model for the log transformation, background correction and
normalization of the PM intensities, following the equation [Irizarry et al.,
2003b]:
T (PMij) = ei + αj + εij, i = 1, . . . , I, j = 1, . . . , J (2.6)
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where T represents the transformation (for background correction, normal-
ization, and log2) of the PM intensities, ei is the log2 scale expression value
found on array i = 1, . . . , I , αj represents the log scale affinity effects for
probes j = 1, . . . , J , and εij represents the random error. The robust linear
fitting procedure using polish median [Tukey, 1977], is considered to estimate
the log scale expression values ei.
RMA has been modified to include different propensities of probes in back-
ground correction in order to undergo non-specific binding (NSB), type of
background often underestimated. This modification of RMA, called GCRMA,
uses probe sequence information to estimate probe affinity to the non-specific
binding (NSB). Each probe affinity is obtained summarizing the sequence in-
formation for the base types (A,T,G or C) at each position (1-25) along the
each probe. The parameters of the position-specific base contributions to the
probe affinity are estimated in a NSB experiment in which only NSB but no
gene-specific binding is expected. The probe affinities allow to estimate the
relationship between the probe sequences and the quantity of NSB, through
the estimation of the function:
NSB = h(affinity) (2.7)
which estimated by fitting a loess curve to MMintensities ≈ MMaffinities
or using any list of negative controls (NC) instead of MM. The background
adjusted intensity is computed as the posterior mean of specific binding given
the observed intensities and the probe sequences. [Wu et al., 2004].
Normalization
Normalization is the adjustment for the differences of the overall probe in-
tensities among arrays. Those differences are due to a variety of technical
reasons like: different efficiencies of reverse transcription, labeling, hybridiza-
tion reactions, physical problems with the arrays, reagent batch effects and
laboratory conditions. Without normalization it is almost impossible to di-
rectly compare measurements from different microarrays. The simplest form
of normalization involves multiplicatively transforming all the intensities on
each array by a factor so that all arrays have the same median probe inten-
sity. There are different linear and non-linear methods hat have been applied
for normalizing Affymetrix microarrays.
Scale Normalization is a linear method that picks a baseline microarray, and
all the other arrays in the experiment are scaled according to the mean inten-
sity of the chosen microarray. It is like to use a selected baseline microarray
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for fitting a linear regression with each of the other microarrays in the exper-
iment, without an intercept term. Then, uses the fitted regression line as the
normalizing relationship. Affymetrix uses a trimmed mean calculated after
removing the lowest and highest 2% of the data.
Some non-linear normalization methods have been implemented and they
tend to have better performance that the scaling ones. Some examples are
cross-validated splines [Schadt et al., 2001], median lines, loess smoothers
[Bolstad et al., 2003], quantile normalization [Bolstad et al., 2003] and vari-
ance stabilization and normalization (VSN) .[Huber et al., 2002, 2003].
Quantile normalization is one of the most reported non-parametric methods
used for normalizing Affymetrix microarrays, which imposes the same em-
pirical distribution of intensities to each array [Bolstad et al., 2003].
This method produces, for different data sets, the same distribution by trans-
forming the quantiles of each set to have the same value. Bolstad et al. [2003]
proposed the next algorithm for the implementation of quantile normaliza-
tion:
1. Given I datasets of length N , create X of dimension N×I, where each
dataset is a column,
2. Set d = (1/
√
I, . . . , 1/
√
I), a vector of dimension I,
3. Sort each column of X to give Xsort,
4. Project each row of Xsort onto d to get X
′
sort,
5. Get Xnorm by rearranging each column of X
′
sort to have the same or-
dering as original X.
The projection is equivalent to taking the average of the quantiles in a par-
ticular row of Xsort and substituting each individual element in that row
by this value, for example, if qj = (qj1, . . . , qjI) is a row in Xsort, then the
corresponding row in X ′sort is given by:
q′j = projdqj =
qj.d
d.d
d =
1√
I
I∑
i=1
qjid = (
1
I
I∑
i=1
qji, . . . ,
1
I
I∑
i=1
qji) (2.8)
Another well known normalization method applied to Affymetrix microar-
rays is Cyclic Loess [Dudoit et al., 2002]. This approach is based upon the
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MA plot, being M the difference between the log expression values of a spe-
cific probe under two different conditions and A the average of the same log
expression values.
For any two arrays i, i′, with probe intensities xji and xji′ where j = 1, . . . , J
represents the probe, Mj = log2(xji/xji′) and Aj =
1
2
log2(xji × xji′) are
calculated and the normalization curve is fitted to the MA plot using loess
method (locally weighted polynomial regression) [Bolstad et al., 2003]. Based
on the normalization curve fitted, new values for Mj are calculated – Mˆj –
and therefore the normalization adjustment is M ′j = Mj − Mˆj. Adjusted
probe intensities are given by x′ji = 2
Aj+
M′
j
2 and x′ji′ = 2
Aj−
M′
j
2 .
Cyclic Loess is carried out in a pairwise manner and when there are more
than two arrays the adjustment for each two arrays is recorded. After look-
ing at all pairs of arrays, a set of adjustments which may be applied to the
set of arrays is: selected, applied and the process is repeated. Usually, one
or two complete iterations through all pairwise combinations are needed to
achieve the normalization. It is a time consuming method because it works
in a pairwise manner. [Bolstad et al., 2003].
Summarization
Summarization is the final step in pre-processing Affymetrix microarray data.
As it was mentioned before, in the Affymetrix microarray design each tran-
script is represented in the microarray by a set of 11 to 20 different probes
(probe set) that hybridized specifically with that transcript product. Sum-
marization is the process of combining the multiple probe intensities for each
probe set to produce an expression value that will serve as an indicator of
the level of expression of a specific transcript.
For probe set summarization in a single microarray it has been used the av-
erage of the differences – avgDiff – between PM and MM intensities of each
probe corresponding to a specific probe set, method no longer recommended
for use due to many flaws motivated by the fact of some MM probe inten-
sities being higher than the corresponding PM probe intensities. The MAS
5.0 algorithm [Affymetrix, 2009] for summarization, in a single microarray,
uses robust average in log scale (One-Step Tukey biweight) to combine the
probe intensities of a specific probe set k, as follow:
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1
nk
nk∑
j=1
log2(PMj − IMj) (2.9)
where nk (usually between 11 and 20) is the number of probes in probe set
k.
In the case of probe set summarization using multiple microarrays, good
examples are the mutiplicative model implemented in dChip software package
[Li and Wong, 2003] and the robust multichip linear model fit on the log scale,
implemented in RMA [Irizarry et al., 2003b].
PTB and U2AF65 background correction, normalization and sum-
marization
As was described previously on this chapter, there are many different ways for
pre-processing Affymetrix microarrays data. Three different approaches were
chosen for pre-processing PTB and U2AF65 RIP-Chip data [Gama-Carvalho
et al., 2006], basically because they have been used in the analysis of RIP-
Chip microarray data or because they were the most reported for the analysis
of GeneChip R© U133 2.0 plus Affymetrix microarrays.
Two probe affinity modeling approaches were used for data pre-processing:
RMA [Irizarry et al., 2003b] and its modification GCRMA [Wu et al., 2004].
These two methods consider only PM on raw intensity scale, quartile normal-
ization, and probe set summarization done by the fitted model obtained via
median polish algorithm. Also, the data were pre-processed using only PM ,
invariant set normalization method [Li and Wong, 2001] and the model-based
method of Li and Wong [2001] for computing expression values.
The boxplots of the three different approaches: Li-Wongo’s Model-Based,
RMA and GCRMA applied to PTB and U2AF65 RIP-Chip data, are showed
in the Figure 2.11. The library affy of Bioconductor allows to make each
pre-processing approach by the R code shown in the appendix A.1.2.
Figure 2.11 shows that each of the three pre-processing methods produced dif-
ferent data distributions, where Li-Wong’s Model-Based and RMA performed
similarly while the GCRMA method was significantly different. These dif-
ferences may lead to different results in the posterior enriched gene selection
affecting the quality of the biological conclusions from the RIP-Chip experi-
ment.
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(a) PTB arrays
(b) U2AF65 arrays
Figure 2.11: Probe values distribution of PTB and U2AF65 RIP-Chip
data before (raw data) and after Li-Wongo’s Model-Based, RMA and
GCRMA pre-processing.
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2.2.2 High level analysis (Enriched Gene Selection)
The aim in most part of the microarray experiments is finding the differences
between gene expression levels under two different cell conditions (treatment
versus control or disease versus healthy), for example, genes responsible for
diseases like cancer are expressed in different levels when the diseased is
present and when it is not. In general, the conditions or states that are be-
ing compared have few differences between them and the lab experiment is
running under the same conditions.
On another hand, the RIP-Chip allows to identify RNAs associated with spe-
cific RBPs, by comparing two different samples: the IP sample, (obtained
by immunoprecipitation of RNAs bounded to a specific RBP, purification
of this subset of RNAs, amplification by PCR, reverse transcription, label-
ing and hybridization), with the Input sample (where all mRNAs expressed
by the HeLa cells are amplified by PCR, reverse transcribed, labeled and
hybridized). It is evident that these two samples are processed in different
lab conditions and that the proportions of mRNAs that are immunoprecipi-
tated (IP sample) are higher than the Input sample. Which is why the genes
that express the immunoprecipitated mRNAs are named enriched genes, and
thanks to this can be detected by comparing the Input samples with the IP
samples.
Many methods have been proposed for the determination of differentially
expressed genes and some of then have been applied to RIP-Chip data. The
goal of these methods is to identify genes that are differently expressed in
the two samples or more, generally using a very low number of microarrays.
An important feature of the methods is the capability to access the number
of false positives [Irizarry et al., 2003b], because it allows to know whether
the results obtained using those methods are reliable.
First studies considered as a criterion to detect genes of interest the fold-
change (FC) [DeRisi et al., 1997], in which the gene expression levels under
two different conditions are compared by the difference of the means of the
transformed intensities (in general log2). The FC has the disadvantage of the
cutoff values being arbitrary and consequently not providing a significant es-
timate for the observed changes in the presence of biological and experimental
variation. Theses variations usually differ from gene to gene and are evident
in some studies that have shown a false positive rate of 60-70%, which is the
main reason for using statistical tests to access the differential expression of
the genes.
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The statistical tests look at various properties of the distributions of a gene’s
expression levels under different conditions, but the mean and the median
are the most often considered through parametric tests, such as the t-test
and moderated t-statistic [Smyth, 2004] and non-parametric tests, such as
the Rank Products test [Breitling et al., 2004].
For assessing the differential expression of a gene under two experimental con-
ditions, the t-test has been one of the most used methods, as well as ANOVA
for more than two groups. For more general trend tests are frequently ap-
plied linear models, parametric method with convenient interpretability of
the model parameter. The linear models are usually computed for each gene
and allow to identify genes of interest, but due the lack of information of their
biological relationship, their joint biological behavior is studied through more
sophisticated modeling approaches like gene network models. in the next sec-
tions some of the most used will be briefly described.
t-test
The t-test is based on the standardized expression level, using the mean and
the variance of the mean expression levels for each gene (of the treatment
and control samples). When the expression level change is large in compar-
ison with the variance of the mean difference, it is possible to assume that
there is a real difference in gene levels and therefore they are differentially
expressed. On the other hand, even if the difference is large, but the gene
values have high variance, they will not be treated as differentially expressed.
The t-score is computed using the following statistic:
T =
Mc −Mt√
S2c
nc
+
S2t
nt
(2.10)
where S2c , S
2
t are the variances in control and treatment samples respectively,
Mc, Mt are the mean levels in control and treatment samples respectively and
nc, nt are the dimension of control and treatment samples respectively.
It is possible to calculate a p-value for each t-score in order to access the
chance for a false positive (the chance is the p-value itself). We should dismiss
genes with p-values higher than some cutoff bound, being 0.01 and 0.05 the
most commonly used. The calculation of the p-value depends as usually of
the kind of samples. Considering that the variances are unknown and that
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the hypothesis of normally distributed data holds, it is used the t-Student
distribution. If the samples are very small or not normally distributed it is
advisable to obtain the p-value by bootstrap or permutation/randomization
methods. [Wit and McClure, 2004].
Lineal models
The central idea of this method, included in the library limma of Biocon-
ductor, is to fit a linear model to the expression data for each gene in order
to estimate the variability in the data. For statistical analysis and assessing
differential expression, limma uses a moderate t-statistic and an empirical
Bayesian method. This results in more stable inference and improved power,
especially for experiments with small numbers of arrays. With Affymetrix
microarrays, linear modeling is an ordinary ANOVA or multiple regression,
where the is fitted for every gene. [Smyth, 2004].
This method assumes a linear model E[yg] = αgX where yg contains the
expression data for the gene g , X is the design matrix and αg is a vector of
coefficients. Here, yTg is the g-th row of the expression matrix and contains
the log-intensities. The contrasts of interest are given by βg = C
Tαg where
C is the contrasts matrix. The coefficients component of the fitted model
contains estimated values for the αg. The contrast step, allows the fitted
coefficients αg to be compared in many ways depending of the questions to
be answered, and estimate the βg. [Smyth, 2004].
The library limma of Bioconductor [Smyth, 2004] produces a moderated t-
statistic that uses a weighted average of s20 (global variance estimate s
2
0 using
all genes’ variances) and s2g, instead of the single gene estimated variance
s2g. This statistic can be shown to follow a t-distribution under the null
hypothesis (also, under normality distribution) with the degrees of freedom
depending on the data.
limma also implements an empirical Bayesian approach to select the differ-
ential expressed genes. The posterior odds of any particular gene g with
respect to contrast βg can be computed, given the joint distribution of T˜g
and S2g , representing the mean and the standard deviation of the expression
values for gene g, respectively. It is a target measure for each gene to be
differentially expressed:
Og =
p(βg 6= 0|T˜g, S2g )
p(βg = 0|T˜g, S2g )
(2.11)
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where T˜g and S
2
g are independent and the distribution of S
2
g does not depend
on βg . [Smyth, 2004].
Following Lonnstedt and Speed [2002], the logarithm of posterior odds:
Bg = logOg (2.12)
can be calculated and it is useful for ranking genes with respect to their
differential expression evidence. [Smyth, 2004].
Rank products
Rank products (RP) is a non-parametric method based on the ranks of the
expression values changes. The method is based on the calculation of the
rank products (RP) from replicate experiments, which is statistically rigor-
ous and can be used to provide reliable significance thresholds to distinguish
significantly regulated genes. At the same time, it provides a statistical way
to determine the significance level for each gene and allows for the flexible
control of the false discovery rate (FDR). [Breitling et al., 2004]
The assumptions made for the RP method are relatively weak: (1) relevant
expression changes affect only a minority of genes, (2) measurements are
independent between replicate arrays, (3) most changes are independent of
each other, and (4) measurement variance is about equal for all genes. [Bre-
itling et al., 2004]
In general, for each gene g in each replicate i with Ni genes, when Ni = N
for all replicates it is possible to calculate the combined probability as a rank
product using the geometric mean rank [Breitling et al., 2004]:
r¯upg = (
I∏
i=1
rupgi )
1
I , (2.13)
where rupgi is the position of the gene g in the list of genes in the i-th repli-
cate sorted by decreasing FC, being rupgi = 1 when the gene is the most
up-regulated. In the same way it is possible to calculate r¯downg but from the
gene list sorted by increasing intensities. These r¯ values (RP values) can be
used to sort the genes according to the likelihood of observing them so high
on the lists of differentially expressed genes just by chance.
The significance level of the RP values is calculated using a permutation-
based estimation procedure that allows to determinate how likely a given
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RP value, or better, is observed in a random experiment. For that, p permu-
tations are generated from I rank lists of length N and the rank products for
all the N genes for each permutation are calculated. After that, cg is set to
count how many times the rank products of the genes in the permutations are
smaller or equal to the observed r¯up.or.downg = min(r¯
up
g , r¯
down
g ) and it is used
for obtaining the expected value for the rank product by: E(RPg) = cg/p.
Finally, FDR is calculated using the equation: FDRg = E(RPg)/r¯
up..or..dwon
g .
[Breitling et al., 2004]
The multiple testing problem
The Multiple Testing Problem arises when researchers try to identify which
genes are differentially expressed between two conditions or between classes,
using a few replicates, testing simultaneously a large number of hypothe-
sis, making more likely to find extreme differential expression values, even
if all null hypothesis are true [Wit and McClure, 2004]. For example, using
t-tests for independent samples when 20,000 genes are examined, with the
aim of identifying each differential expressed gene (under the null hypothesis
of genes not being differentially expressed), may lead to 5% of the genes to
have p-values <0.05. This would imply that 1000 genes would be identified
as being significant at that p-value level, resulting in an expected number of
1000 false positives.
Various strategies have been proposed to deal with this problem: the signifi-
cance analysis of microarrays (SAM) [Tusher et al., 2001]; the false discovery
rate (FDR) [Benjamini and Hochberg, 1995]; the positive false discovery rate
(pFDR) [Storey, 2002]; and the Q-value, a Bayesian posterior p-value or
pFDR analogue of the p-value [Storey, 2003].
Bonferroni correction
The Bonferroni correction is a method for controlling the multiple testing
problem associated with the familywise error rate (FWER) in microarray
experiments. This conservative method classifies each gene with a p-value
less than q/N as differential expressed, being q the desired FWER while N
is the number of genes are being tested. For example, a cutoff of 0.00001
for the p-value should be chosen in order to have a FWER of 0.01 level over
1000 comparisons.
Bonferroni correction indeed reduces chance for false positives but may cause
a large number of false negatives – genes that may be differential expressed
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but were not select due to the small p-value threshold. [Wit and McClure,
2004].
False discovery rate
The false discovery rate (FDR) [Benjamini and Hochberg, 1995] is the ex-
pected proportion, E(Q), of false positives among the genes declared as dif-
ferential expressed:
Q =
V
V + S
(2.14)
where V is the number of false positives, S the number of true positives
and V + S = R the number of genes declared to be significant (known). Q
expected value is:
E(Q) = E
(
V
V + S
)
= E
(
V
R
)
(2.15)
To control FDR, ensuring that it is less than a given threshold q, letH1, · · · , HN
be the null hypotheses in increasing order of their p-values p1, . . . , pN . For a
given q, find the largest i, say j, such that
pi ≤ i ∗ q
N
(2.16)
Then, reject (declare differentially expressed genes) all H(i) for i = 1, . . . , j.
It will guarantee that the false positives amount q is not exceeded. The FDR
assumes that the gene expression of genes on the microarray is independent
but in many cases their expressions are correlated.
Enriched gene selection for PTB and U2AF65 RIP-Chip pre-processed
data
The enriched gene selection was performed using the expression data ob-
tained by the RMA method applied to PTB and U2AF65 RIP-Chip data.
As it was mentioned before, RMA performed similar to Li-Wong’s model-
based and better than the GCRMA pre-processing methods. RMA is one of
the most cited pre-processing methods given its accuracy and performance
on Affymetrix microarray data when it is associated with the gene selection
methods used in this section. [Kadota et al., 2009].
Three different enriched gene selection methods with different approaches
were applied to the PTB and U2AF65 pre-processed data (R code showed in
the appendix A.1.2):
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1. Fold change (FC > 1.5), t-test and FDR (< 0.05) by using dChip
software [Li and Wong, 2003].
2. Fit linear models and the statistics B calculated by the empirical
Bayesian approach. Moreover, multiple testing procedures (p-value <
0.05) by using the Bioconductor library limma [Smyth, 2004].
3. The non-parametric test Rank Products with FDR < 0.05 by using the
R library RankProd [Hong et al., 2006].
These three differentially expressed gene selection methods are commonly
used and were applied with FDR < 0.05 as threshold for selecting significant
enriched genes. Table 2.3 shows the differences in the number of enriched
genes selected by each method, being Rank Products (RP) the most conser-
vative, selecting only 134 and 449 genes as enriched genes that bind their
expressed mRNAs to the RBPs PTB and U2AF65, respectively, when more
than 3000 were expected [Gama-Carvalho et al., 2006].
This means that each applied method has different false positive and false
negative associated levels. If they are too conservative like RP, the false neg-
ative error is likely higher that in the others and vice versa. In general, the
applied methods may have a high false negative percentage.
Table 2.3: Enriched genes select that bind their expressed mRNAs to
PTB and U2AF65.
Method PTB Genes U2AF65 Genes
Linear model - eBayes 1753 1396
Fold Change t-statistic 2803 1884
Rank Products 134 449
Figure 2.12 shows differences not only in the number of genes selected but
also in the identification of those genes.
Figure 2.12 shows that only 2 and 223 enriched genes were selected simul-
taneously by the three methods applied to PTB and U2AF65 RIP-Chip pre-
processed data respectively and most of the enriched genes were selected from
one specific method. 93.3% and 27,65% of the genes were selected by fitting a
linear model – eBayes, applied to PTB and U2AF65 RIP-Chip pre-processed
data, respectively.
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(a) PTB (b) U2AF65
Figure 2.12: Venn diagram showing enrichmed genes selected by fitting
a linear model – eByaes, Fold change (FC) – t-test, and Rank Products
(RP).
The differences in the selected genes in others microarray experiments by ap-
plying different gene selection methods, have been already reported [Breitling
et al., 2004] and could involve problems in the confidence of the results. This
is very important when those results must support biological conclusions and
further experiments.
Is important to point out that in PTB and U2AF65 RIP-Chip experiments
more that 20% of the genes should be enriched and therefore, the assump-
tion of a few expression differences between experimental conditions is not
fulfilled, likely affecting the performance of this methods when applied for
enriched gene selection.
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New methods for RIP-Chip
data analysis
3.1 Introduction
The systematic identification of RNA targets has provided clues to unsus-
pected functions of well-known RBPs and they have been identified using
microarrays. To achieve this, the RBP is purified together with its asso-
ciated RNAs after immunoprecipitation using an epitope tag or antibodies
raised against the RBP. The RNAs from the immunoprecipitation are then
isolated, PCR purified, labeled and hybridized to DNA microarrays [Ger-
ber et al., 2004, Gama-Carvalho et al., 2006]. This technology is analogous
to Chromatin immunoprecipitation on chip (ChIP-Chip) [Hanlon and Lieb,
2004] and is called RNA immunoprecipitation on chip (RIP-Chip).
Chromatin immunoprecipitation on chip (ChIP-Chip) is a popular technique
to study the in vivo targets of DNA-binding proteins at the genome level.
In the first step of this technique, the target protein (TP) is cross-linked by
a formaldehyde fixation with the DNA site where it is binding to in vivo
environment. It is followed by cell lysis and the DNA fragmentation using
sonication. Then, double-stranded DNA fragments (1 kb or less in length)
cross-linked to the TP are immunoprecipitated out of the set of DNA frag-
ments by using a specific antibody to the TP and after purification, the DNA
complex are split and the DNA strands are purified. The next step are ampli-
fication, denaturation, labeling of the single-stranded DNA fragments with a
fluorescent tag and finally, hybridization to a DNA microarray. [Hanlon and
Lieb, 2004].
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It is evident how similar the ChIP-Chip and the RIP-Chip techniques are,
both performed in different ways to the DNA expression experiments. In
particular, the RIP-Chip technique the immunoprecipitated (IP) and input
samples are processed in different ways [Gama-Carvalho et al., 2006] and
are hybridized separately, obtaining two microarrays with strong differences
in the gene expression levels. As it was presented in Chapter 2, the main
problem is related to the pre-processing methods, like RMA [Irizarry et al.,
2003b], dChip [Li and Wong, 2003], etc., implemented with the assumption
that there are few differences in the expression levels between conditions,
which is not true in the RIP-Chip experiments, and there are not specific
methods developed for this kind of experiments.
Due the lack of methods implemented to pre-processed RIP-Chip data and
its similarities with the ChIP-Chip technique, in particular when in the hy-
bridization step are used Affymetrix tiling microarrays (closely related to
the Affymetrix GeneChip microarrays used in RIP-Chip), a pre-processing
method developed in this thesis, applied to U2AF65 RIP-Chip microarray
data, is presented in this chapter, following the spirit of the algorithm pro-
posed by Johnson et al. [2006] for analyzing ChIP-Chip data obtained by
sample hybridization with Affymetrix tiling microarrays.
This chapter presents a simple linear model that estimates the baseline probe
behavior using the probe sequence for background correction of Affymetrix
microarray data. This model is based on the previous research made by
Johnson et al. [2006], Naef and Magnasco [2003] and Wu et al. [2004], that
proposed different unspecific hybridization models, and additionally this new
model as in the Johnson et al. [2006] algorithm uses the information asso-
ciated with each microarray for its own pre-processing. Basically, a linear
model is fitted (using an iterative procedure) in order to predict each probe
intensity and standardize it afterwards. In this way it takes the advantage
of high density of the Affymetrix microarrays, where each U133 2.0 plus mi-
croarray contains more than 1.2 million probes, and the overfit of the models
is not a problem. Thus, the assumption of a small number of differences
usually applied for the pre-processing methods is not necessary.
After pre-processing, the enriched genes selection is a crucial step of the
of RIP-Chip data analysis and any other kind of microarray data analysis,
therefore two new methodologies are presented in this chapter. The first one
is inspired in the Johnson et al. [2006] methodology designed for the ChIP-
Chip data analysis. The idea is to summarize the probe set intensity on the
basis of the standardized probe intensities, resulting in a statistic which we
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named ENRval – enriched value.
The motivation for developing the second method, was due to the fact of
the methods for Affymetrix data analysis using a unique value to represent
the behavior of the levels of the probes within a probe set. However, it is
generally known that the variability within the probe set is high, even if
the probes intensities have been corrected. An alternative methodology is
presented for enriched gene selection, which takes into account the probe
intensity variability in each probe set. This is a non-parametric test based
on ranks, and a permutation test is performed for obtaining a FDR for each
standardized probe intensity.
Finally, the evaluation of the methods presented here is made using the data
of U133 Spike-In experiment [Cope et al., 2004].
3.2 Sequence-specific affinity models estima-
tion
The probe behavior estimation model proposed in this thesis was motivated
by the idea of taking advantage of the more than 1.2 million 25-mer oligonu-
cleotide probes present on each Affymetrix U133 Plus 2.0 array, in order to
obtain an accurate and robust prediction of probe sequence effects on non-
specific hybridization background. Finally, for their own pre-processing not
requiring the assumption of small differences between microarray conditions.
The Naef and Magnasco [2003] research on the labeling and effective binding
in oligonucleotide microarrays serves as motivation for the implementation
of a different approach to estimate sequence-specific affinity models for pre-
processing Affymetrix microarrays . Naef and Magnasco [2003] proposed a
model where they found that the variation within a PM probe set is sequence
dependent, by fitting brightness B of PM probes ([RNA] concentration: the
median of the PM brightnesses) against their own sequence composition:
ln
(
B
[RNA]
)
=
∑
lk
SlkAlk =
∑
lα
Slα
∑
k
AlkPkα (3.1)
where l = A,C,G, T is the letter index and k = 1, . . . , 25 the position along
the 25-mer probe; Slk is a Boolean variable equal to 1 if the probe sequence
has letter l at site k and 0 otherwise; and thus Alk’s are per-site, per-letter
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affinities. Note that
∑
l Slk = 1 for all k. In the last equality Naef and
Magnasco [2003] use an expansion of the spatial dependence in orthonormal
polynomials Pkα on set {1, . . . , 25}.
Naef and Magnasco [2003] did not include nearest-neighbor interactions along
the transcript length in their model because they found it does not improve
the fit enough to justify the increase in the number of parameters, but found
that the insertion of position-dependent affinities produces a strong improve-
ment in their model.
Wu et al. [2004] introduced the Non-Specific Background (NBS) adjustment
in their GCRMA method for pre-processing Affymetrix microarrays. They
fitted the model of the Equation 3.1 to log intensity data using a spline with
5 degrees of freedom, instead of the polynomial of degree 3 proposed by Naef
and Magnasco [2003], and used these affinity estimates to describe NSB noise
in GCRMA assuming that:
PM = OPM +NPM + E
MM = OMM +NMM + ΦE (3.2)
where O represents the optical noise, N represents NSB noise, E is a quantity
proportional to RNA expression (the quantity of interest) and the parameter
Φ ∈ (0, 1) accounts for the fact that for some probe pairs the MM detects
signal. The large amount of data allows a very precise estimate of model
parameters and the GCRMA model, as a background adjustment procedure,
is formalized as the statistical problem of predicting E given that the ob-
served PM and MM and the affinity estimates to describe NSB noise [Wu
et al., 2004]. It is important to annotate that the GCRMA assumes that
there are a small number of differences between microarrays under different
conditions, and uses all microarrays in the experiment for the pre-processing
step.
Johnson et al. [2006] inspired in the previous work of Naef and Magnasco
[2003] and Wu et al. [2004], propose an algorithm called Model-based Analysis
of Tiling-arrays (MAT), where they use a probe behavior model fitting as part
of the algorithm for pre-processing, independently for each Affymetrix tiling
microarray. They propose the following tiling array probe affinity model
[Johnson et al., 2006]:
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log(PMi) = αniT +
25∑
j=1
∑
k∈{A,C,G}
βjk Iijk +
∑
k∈{A,C,G,T}
γkn
2
ik + δ log(ci) + εi,
(3.3)
where:
• PMi Perfect Match (PM) probe intensity value of the probe i;
• nik is the number of times nucleotide k occurring in probe i;
• α is the baseline value (intercept or constant) based on the number of
T nucleotides on the probe, e.g., 25α is the baseline when the probe
sequence is a run of 25 T nucleotides;
• Iijk Indicator function such that Iijk = 1 if the nucleotide at position j
in probe i is k, and Iijk = 0 otherwise;
• βjk Effect of each nucleotide k (except T, which is already modeled in
α) at each position j;
• γk is the effect of nucleotide count squared;
• ci is the number of times that the sequence of probe i appears in the
genome. Affymetrix tiling array libraries provide the 25-mer sequence
of every probe, which we mapped to the non-repeat-masked newest
(May 2004) version of the human genome assembly;
• δ is the effect of the log of the probe copy number;
• εi is the probe-specific error term, assumed to follow a normal distri-
bution.
The Model is fitted by ordinary least squares to each array separately using
all of the probes on a tiling array. After parameter estimation, the model
can predict the probe i baseline intensity, mˆi, given its probe sequence and
copy number of its sequence in the genomic regions that is represented in
the tiling microarray. After that it is possible to correct and standardize the
probe values, eliminating the need of data normalization. [Johnson et al.,
2006]
Attending the technical similarities between RIP-Chip and ChIP-Chip tech-
niques and the pre-processing methods limitations, in analogy with the work
of Johnson et al. [2006] on tiling arrays data analysis (where the authors
65
Chapter 3. New methods for RIP-Chip data analysis
proposed a probe affinity model for background correction and the previous
Sequence-Specific probe behavior models for gene expression microarrays pro-
posed by Naef and Magnasco [2003] and Wu et al. [2004]), it is proposed the
following linear Sequence-Specific affinity model for background correction
of gene expression Affymetrix arrays [Barreto-Hernandez et al., 2011]:
log(PMi) =
25∑
j=1
∑
k∈{A,C,G,T}
βjk Iijk +
∑
k∈{A,C,G,T}
γkn
2
ik + εi (3.4)
where:
• PMi Perfect Match probe intensity value;
• njk is the number of times nucleotide k occurring in probe i;
• Iijk Indicator function such that Iijk = 1 if the nucleotide at position j
in probe i is k, and Iijk = 0 otherwise;
• βjk Effect of each nucleotide k at each position j;
• γk is the effect of nucleotide count squared;
• εi is the probe-specific error term, assumed to follow a normal distri-
bution.
The linear sequence-specific affinity model for background correction (Equa-
tion 3.4) was applied to each microarray in the U2AF65 RIP-Chip experiment
data (R code shown in the appendix A.2.1). This final model was obtained
after testing different approaches with base in the Equation 3.3 which results
are showed in the Table 3.1.
Given the differences between gene expression and tiling microarrays, the
number of times that the sequence of probe i appears in the genome (ci) and
the effect of the probe copy number (δ) in the Equation 3.3 were not included
in the model (Equation 3.4). Due to that, the gene expression Affymetrix
microarrays are designed using probes that only recognize one specific tran-
script and therefore, their probe signals correspond to a one transcript for
each probe and not multiple genome fragments that may increase the mag-
nitude of the probe signal like could occur with tiling microarrays.
As it is shown in the Table 3.1, when the model setup is done using the effect
of nucleotide count squared (γk) had better fit (R
2= 0.02681) than when the
model was fitted without it (R2= 0.01853), although none of them represents
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Table 3.1: Results for different combinations of the presence or not of γk,
njTα and thymine (T) affinity terms in the linear affinity model [Equation
3.4] fitted to the U2AF65 Input sample 1.
Model including: Multiple R2 p-value
γk, njTα and no T affinities 0.02681 < 2.2× 10−16
no γk, njTα and no T affinities 0.01853 < 2.2× 10−16
no γk, no njTα and no T affinities 0.01853 < 2.2× 10−16
γk, no njTα and T affinities 0.02681 < 2.2× 10−16
a good model. Additionally, the effect of the thymine count (njTα) were re-
moved from the model and the thymine affinities effect was included due the
equal model fit results (Table 3.1).
The linear model (Equation 3.4), fits binding affinities to the sequence com-
position by examining the PM signal intensity, the contribution of each nu-
cleotide in each sequence position and the effect of adenine, thymine, cyto-
sine, guanine (ATCG) nucleotides count. This model was fitted using a ran-
dom sample of 100,000 sequences (the calculations using the R code placed in
appendix A.2.1 are computing demanding in terms of memory and time) and
accounted for 3 to 4% of the variation in the arrays (based on the multiple
R2 of the model).
The linear sequence-specific affinity model (Equation 3.4) was modified try-
ing to improve its fit by taking into account the nucleotide position-specific
interaction, replacing the expression:
25∑
j=1
∑
k∈{A,C,G,T}
βjk Iijk (3.5)
by
26−it∑
j=1
∑
k1,...,kit∈{A,C,T,G}
βjk1...kit Iijk1 . . . Ii(j+it−1)kit (3.6)
where it is the interaction nucleotide number with the nucleotide k in the
probe i. This modification originates the model:
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log(PMi) =
26−it∑
j=1
∑
k1,...,kit∈{A,C,T,G}
βjk1...kit Iijk1 . . . Ii(j+it−1)kit +
+
∑
k∈{A,C,G,T}
γkn
2
ik + εi (3.7)
where, in order to improve the model fit, the contribution of each nucleotide
in each sequence position to the binding affinity (Equation 3.5) was replaced
by contribution of each nucleotide in each sequence position to the binding
affinity plus its interaction with the neighbor nucleotides (Equation 3.6).
Table 3.2 shows the results after applying this model (R code shown in the
appendix A.2.1) with different setups: 2, 3 and 4 interacting nucleotides in
comparison with the original no-interaction model. We obtained (Figure 3.1)
better fitting results when the number of interacting nucleotides is increased
(more than 58% for 4 interacting nucleotides) which is evident in the Figure
3.1d, where the Q-Q plot (Quantile-Quantile plot) of the model where in-
teract 4 nucleotides shows the better fit. However, increasing the number of
interacting nucleotides turns out to be more computing demanding in terms
of memory and time. This is the reason why fitting for 3 and 4 nucleotides
was only possible using a random sample of 20,000 and 8000 probes, respec-
tively, from each array data set. When the number of probes in the random
sample is much smaller than the total number of probes in the array, is intro-
duced certain variability in the parameters estimation, especially when the
sample has less than 10,000 probes.
Table 3.2: Results of the no-interaction model (Equation 3.4), and the
nucleotide interaction (2, 3 and 4 interacting nucleotides) model (Equation
3.7) applied to the U2AF65 Input sample 1.
Model Multiple R2 p-value
No-interaction 0.02681 < 2.2× 10−16
2 Nucleotides interaction 0.06918 < 2.2× 10−16
3 Nucleotides interaction 0.124 < 2.2× 10−16
4 Nucleotides interaction: 8K sample 0.5861 7.48× 10−11
68
3.2. Sequence-specific affinity models estimation
(a) No-interaction (b) 2 Nucleotides interaction
(c) 3 Nucleotides interaction (d) 4 Nucleotides interaction
Figure 3.1: Residuals plots of the fitted model, Equation 3.7, using
different numbers of interacting nucleotides applied to the U2AF65 Input
sample 1.
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The 3 nucleotides interaction model was used for trying to improve the cor-
relation between predicted probe intensities and the observed values, by the
implementation of the following iterative process:
1. Linear model parameters estimation.
2. If the difference between multiple R squared (R2) of the fitted model
and the multiple R2 of the fitted model in the previous iteration is >
0.001, the outliers are removed from the sample and the process returns
to step 1.
3. Probe baseline intensity is estimated and the process is stopped.
With the idea of modeling the non-specific hybridization in terms of probe
sequence, the iterative process was implemented for removing outliers after
fitting the 3 nucleotides interaction model (Equation 3.7), using an initial
random sample of 20,000 probes sequences. The process stops when there
are no significant differences between the last fitted model and the previous
one which includes the removed outliers (R2v − R2v−1 < 0.001, where v is the
iteration number).
The linear model parameter estimation and the posterior probe baseline in-
tensity estimation, mˆi, are calculated using the lm R library (code shown in
the appendix A.2.1) and applied to each microarray data set independently.
After the iterative process the model accounted for 42 to 58% of the varia-
tion in the arrays explained (Table 3.3), removing 18 to 28% probes in the
probe sample. Mainly, this process removes high intensity values, which cor-
respond to the specific hybridized probes, and increases the proportion of
non-specific hybridized probes in the sample data, making the final fitted
model more specific to the non-specific hybridization.
The residuals (Figures 3.2, 3.3 and 3.4) of the fitted model after the iter-
ative process, on each U2AF65 RIP-Chip microarrays, were approximately
normally distributed.
3.3 Probe standardization
After predicting each probe intensity mˆi using the iterative process, a stan-
dardization for each probe is made on each array independently, using the
Equation [Johnson et al., 2006]:
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(a) Input 1 iteration 1 (b) Input 1 final iteration
(c) IP 1 iteration 1 (d) IP 1 final iteration
Figure 3.2: Residuals histograms of the iterative process fitting the 3
nucleotides interaction linear model to the U2AF65 RIP-Chip samples.
Part A
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(a) Input 2 iteration 1 (b) Input 2 final iteration
(c) IP 2 iteration 1 (d) IP 2 final iteration
Figure 3.3: Residuals histograms of the iterative process fitting the 3
nucleotides interaction linear model to the U2AF65 RIP-Chip samples.
Part B
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(a) Input 3 iteration 1 (b) Input 3 final iteration
(c) IP 3 iteration 1 (d) IP 3 final iteration
Figure 3.4: Residuals histograms of the iterative process fitting the 3
nucleotides interaction linear model to the U2AF65 RIP-Chip samples.
Part C
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Table 3.3: Results of the iterative process using 3 nucleotides interaction
linear model, applied to Gama-Carvalho et al. (2006) U2AF RIP-Chip
experiment.
Microarray Iteration number R2 Outliers
Input1 18 0.421259224 3950
Input2 12 0.482873124 3634
Input3 16 0.48839486 4286
IP1 15 0.437264942 4500
IP2 18 0.41968973 3680
IP3 21 0.587910312 5631
ti =
log(PMi)− mˆi
SDiaffinity bin
(3.8)
where mˆi is the predicted probe i baseline intensity and SDi affinity bin is
the observed sample variance estimated within each affinity bin.
Following Johnson et al. [2006] suggestion, using the R code shown in the ap-
pendix A.2.2, all probes on an array were divided into bins containing 3000
probes predicted to have similar intensities mˆi. Each probe’s variance was
estimated from the sample variance of all probes in its specific bin. Figure 3.5
shows that normalization of U2AF65 RIP-Chip microarray data is evidently
required. However, after probes standardization (Figure 3.5), the t-values
calculated using the Equation 3.8 do not require further normalization and
could be compared directly.
3.4 Probe set summarization
A probe set score (PSsco) is calculated as follows [Johnson et al., 2006]:
PSsco =
√
np × TMs (3.9)
where TMs is the trimmed-mean of the t-values of the probe set s, ob-
tained by removing the top 10% and bottom 10% t-values, and np ∈ {11 ×
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(a) PM intensities U2AF65 RIP-Chip microarrays
(b) Standardized t-values U2AF65 RIP-Chip mi-
croarrays
Figure 3.5: Boxplots of PM intensities and standardized t-values U2AF65
RIP-Chip microarrays.
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0.8, . . . , 20× 0.8} is the number of probes used to calculate TMs.
For multiple replicates, PSsco are calculated pooling all t-values for a specific
probe set across all replicates. The higher the number of replicates, the higher
will be the prediction confidence.
3.5 Enriched value (ENRval)
We propose the probe set enriched value (ENRval), to be calculated as fol-
lows:
ENRval = PSscoIP − PSscoInput (3.10)
When there are more than 2 experimental replicates, the ENRvals are di-
vided by SDInput (standard deviation of the t-values used in PSscoInput
calculation). This reduces the score in very noisy regions or where the Inputs
samples give inconsistent results.
A p-value for each ENRval is calculated assuming the null distribution to be
symmetric around the ENRvals median and the negative values correspond
to the non enriched genes. This symmetry is imposed by forcing the second
half distribution to be the ”mirror” of the lower half distribution (ENRvals
smaller than the median), under the assumption of these ENRvals corre-
sponding to non enriched values.
The R code shown in the appendix A.2.3 is used for processing the stan-
dardized probe values ti of U2AF
65 and to make the calculation of probe set
scores (PSsco), enriched values (ENRvals) and p-values. Table 3.4 shows
the number of genes selected using the proposed enriched values (ENRvals)
at different p-value levels applied to the standardized probes.
It is important to remark that the number of enriched genes selected with a
p-value less than 0.05 is approximately the expected number to be associated
with U2AF65 (3200), sharing a high percentage (66%) of the genes reported
in Gama-Carvalho et al. [2006]. Selected genes also include the genes: ahsa2,
gas2l1, cdkn1b, ZNF174 and AHSA2, verified by real time PCR (RT-PCR)
as targets of the U2AF65 by the same authors.
It is possible that some of those differences were due to the application of
normalization methods without having into account the differences in the
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Table 3.4: Enriched genes selected using ENRvals at different p-values
level. ENRvals calculated from the standardized t-values.
p-value Enriched Genes
< 0.001 762
< 0.01 1622
< 0.05 3200
< 0.1 4584
data distribution between samples.
ENRvals allows a consistent enriched gene selection, but it is important to
benchmark the proposed method, which is presented in the Section 3.7 of this
chapter, using the U133 Spike-In data set – standard microarray experiment
results used in the development and comparison of differential expression
analysis methods. [Cope et al., 2004]
It is evident that there is space for improving the unspecific hybridization
prediction and in this way improving the background correction. Most im-
portant, is that there is the possibility of obtaining better approaches of using
the data of the high density microarrays for its own pre-processing, facilitat-
ing the microarrays comparison when technics like RIP-Chip are applied.
3.6 New rank based approach for enriched
gene selection
ChIP-Chip experiments have used Tiling Affymetrix microarrays, which are
designed in a different way to the GeneChip R© Affymetrix microarrays used
in RIP-Chip technology. The Tiling microarrays probes are short fragments
(25 pb in Affymetrix) designed to cover the entire genome or contiguous re-
gions of the genome.
Johnson et al. [2006] methodology implements the PSsco value to represent
the consecutive hybridized probes values in DNA window of ≈ 600 pb. These
values are used to determine the sites where a specific protein binds to the
DNA, main purpose of the ChIP-Chip technology.
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In another hand, the GeneChip R© Affymetrix microarrays, as was explained
before, contain a probe set of 11 up to 20 different probes representing tran-
scripts (gene, RNA, etc) and in the case of the GeneChip R© U133 2.0 plus,
there are more than 54,000 of these transcripts.
An alternative methodology is presented in this section for enriched gene
selection, based in the standardized probe intensity (t-values) variability in
each probe set, corresponding to a specific gene, in both immunoprecipitated
(IP) and Input samples, instead of the summarization of each probe set and
the posterior ENRval calculation.
The first step is to calculate the difference between the t-values of each probe
pair, IP and Input samples, as follows:
dtijk = tijk(IP ) − tijk(Input) (3.11)
for:
i = 1, . . . ,M M is the total array number -IP or Input-;
j = 1, . . . , N N is the total probe set number in the array;
k = 1, . . . , n n is the probe number in each probe set.
These dtijk values will be used for enriched gene selection using a rank based
approach, where different ranks for each gene and their the total rank RT
are calculated.
The following step is to calculate the dtij mean of each probe set (gene) in
each experiment as follows:
dtij =
∑n
k=1 dtijk
n
(3.12)
for:
i = 1, . . . ,M
j = 1, . . . , N
and the dtj mean of each probe set across all experiments as follows:
dtj =
∑M
i=1
∑n
k=1 dtijk
M ∗ n (3.13)
for:
j = 1, . . . , N
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Then, the mean of the differences between dtijk and its probe set mean, dtij,
across all experiments pairs are calculated as follows:
Tpssj =
∑M
i=1
∑n
k=1 |dtijk − dtij|
M ∗ n (3.14)
for:
j = 1, . . . , N
and the mean of the differences between the means of a probe set across all
experiments dtij and their mean dtj, for each gene as follows:
Tpsj =
∑M
i=1 |dtij − dtj|
M
(3.15)
for:
j = 1, . . . , N
Finally four different rankings are proposed corresponding to different vari-
ability measure approaches, having into account the variability among probes
in different experiments and among probe set levels, that are calculate as fol-
lows:
RP1j → position of dtj − Tpssj
sorting {dtj′ − Tpssj′}j′=1,...,N by increasing values,
RP2j → position of dtj + Tpssj
sorting {dtj′ + Tpssj′}j′=1,...,N by increasing values,
RP3j → position of dtj − Tpsj
sorting {dtj′ − Tpsj′}j′=1,...,N by increasing values,
RP4j → position of dtj + Tpsj (3.16)
sorting {dtj′ + Tpsj′}j′=1,...,N by increasing values.
for:
j = 1, . . . , N
and the total rank is as follows:
RPTj =
4∏
l=1
RPlj (3.17)
for:
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j = 1, . . . , N
RPTj values are put in increasing order, where the top values (smallest) cor-
respond to the enriched genes.
The expected number of times each RPTj is greater than other RPT. corre-
sponds to the E-value for gene j. If one considers m permutations – each
permutation i′ consisting of permutating separately each RPlj and recalculat-
ing RPTj , this time called RPT.Permut i′j – the E-value can be approximated
as follows:
E − valuej = zj
m
(3.18)
for:
j = 1, . . . , N
where:
m is the total number of permutations and
zj = #
{
j′ = 1, . . . , N : RPT.Permut i′
j′
≤ RPTj for i′ = 1, . . . ,m
}
The false discovered rate (FDR) for each probe set is calculated as follows:
FDRj =
E − valuej
rankj
(3.19)
for:
j = 1, . . . , N
and
rankj – position of transcripts (genes) j in the list of all genes
sorted by increasing RPTj value, corresponding to the number of
genes accepted as significantly enriched.
The R code shown in the appendix A.2.4 is used for processing the standard-
ized probe values ti of U2AF
65 and to make the calculation of this new rank
based approach for enriched gene selection.
The different rank lists and the RPTj for each transcript j and its corre-
sponding E-values and FDR were calculated. Table 3.5 shows the number of
genes selected at different E-value levels and FDR < 0.05.
80
3.7. Methods benchmark
Table 3.5: Enriched genes selected using the new rank based approach
at different E-values level. Rank indexes calculated from the standardized
t-values.
E-value Enriched Genes
< 0.001 483
< 0.01 1219
< 0.05 2530
< 0.1 3618
The number of enriched genes selected is 2530 for a E-value < 0.05, a very
small number in comparison to the expected number of mRNAs to be bind-
ing with U2AF65 (≈20% of the transcripts). However, these results share
a higher percentage (87%) of the genes reported in [Gama-Carvalho et al.,
2006] than ENRval method (66%) with the same reported genes. Concerning
this non-parametric enriched gene selection, ENRval method shares 78.3%
of the genes selected.
The list of enriched genes include the genes: ahsa2, gas2l1, cdkn1b, ZNF174
and AHSA2, verified by real time PCR (RT-PCR) as targets of the U2AF65
by Gama-Carvalho et al. [2006].
It is possible that some of those differences are due to the application of nor-
malization methods without having into account the differences in the data
distribution between samples, but also the effect of the high variability of the
probe intensity levels in each probe set.
This new non parametric method for enriched gene selection is consistent
with previous reposts [Gama-Carvalho et al., 2006], but as it was mentioned
for the ENRval method it is important to benchmark this method. That is
what will be done in the next section.
3.7 Methods benchmark
The developed methods were benchmarked using the data of U133 Spike-In
experiment, which was made some years ago and is used in the development
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and comparison of differential expression analysis methods [Cope et al., 2004].
The U133A Spike-In dataset was produced by an experiment that has three
technical replicates of 14 separate hybridizations of 42 spiked transcripts se-
lected, based on their absent expression in background total RNA isolated
from a HeLa cell line (ATCC CCL-13). Thirty of the spiked transcripts cor-
respond to cDNA clones isolated from total RNAs of a lymphoblast cell line
(and are not expressed in the HeLa cell line), eight of the spiked transcripts
are made from artificial sequences, and the remaining four spiked transcripts
are Affymetrix eukaryotic controls are that available as part of a poly A
spike control kit. There are fourteen groups of three genes each. The con-
centration of each gene within a group is spiked at the same concentration. A
cyclic latin square was used for the group concentrations (Tables 3.6 and 3.7).
Specifically, the dosing pattern (Tables 3.6 and 3.7) for Group 1 across 14
arrays is 0, 1/8, 1/4, 1/2, 1, 2, 4, . . . , 256, and 512 pM, for Group 2 is
1/8, 1/4, 1/2, 1, . . . , 512, and 0 pM, and so on until Group 14, which has
a pattern of 512, 0, 1/8, 1/4, . . . , 128, and 256 pM. Each pattern appears
on three replicate arrays, yielding a total of 42 arrays.
There are 11 probes per probe set for each of 38 genes and 20 probes per probe
set for the four Affymetrix eukaryotic controls. Additional information about
this experiment is available at the Affymetrix website, www.affymetrix.com/
support/technical/sample data/datasets.affx.
For benchmarking the methods presented in this chapter, three different
Spike-In experiment hybridizations are selected: hybridizations 1, 8 and 14
and used to simulate RIP-Chip enrichment differences (see the values in red,
Tables 3.6 and 3.7). Both combinations (hybridization 1 as Input and 8 as
IP; 1 as IP and 14 as Input) were processed independently using the R code
shown in the Appendices A.2.3 and A.2.4 .
The results on Table 3.8 showed that the developed method has better ac-
curacy when the gene expression differences between conditions (Input and
IP) are high, as one can see in the combination: 1 (as Input) and 8 (as IP);
where 20/21 and 19/21 Spike-in genes were classified correctly by ENRval
and the new ranks approach methods respectively. When the concentration
differences between conditions (IP and Input) are small, the accuracy de-
crease as one can see in the combination: 14 (as Input) and 1 (as IP), where
only 21/39 and 19/39 Spike-in genes were classified correctly by ENRval and
the new ranks approach methods respectively.
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Clearly, these two methods have good accuracy when the differences in con-
centrations of the transcripts is high, which is the common behavior of the
enriched genes in the RIP-Chip experiments. However, they require adjust-
ments to make them more sensitive and precise. Those adjustments could be
made through: improving the background correction model; applying other
types of trimming for the summarization and calculation of the ENRvals ;
or finding other ways to measure the variability of the probe set trying to
improve the sensibility of the new ranks based approach for enriched gene
selection.
Additionally, further work could consider the mixture of part of the method-
ology proposed in this thesis with other methods, which is common in mi-
croarray data analysis.
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Table 3.8: Benchmark results of the ENRval and new ranks based ap-
proach for enriched gene selection.
Spike-In Exp1 Exp8 Exp14 ENRval RPT ENRval RPT
Ex 8-1 Ex 8-1 Ex 1-14 Ex 1-14
203508 at 0 8 512 22 22 22298 22298
204563 at 0 8 512 21 23 22299 22299
204513 s at 0 8 512 19 17 22300 22300
204205 at 0,125 16 0 18 21 6054 8643
204959 at 0,125 16 0 16 3 12943 15242
207655 s at 0,125 16 0 13 7 18259 15410
204836 at 0,25 32 0,125 14 16 3399 5370
205291 at 0,25 32 0,125 20 20 9846 10247
209795 at 0,25 32 0,125 17 15 8728 4973
207777 s at 0,5 64 0,25 10 8 2341 5809
204912 at 0,5 64 0,25 15 12 8264 6766
205569 at 0,5 64 0,25 9 6 4855 6113
207160 at 1 128 0,5 6 13 3511 4591
205692 s at 1 128 0,5 7 11 37 49
212827 at 1 128 0,5 11 18 5001 3905
209606 at 2 256 1 8 14 62 133
205267 at 2 256 1 3 4 74 116
204417 at 2 256 1 4 2 33 22
205398 s at 4 512 2 5 10 36 87
209734 at 4 512 2 1 1 506 408
209354 at 4 512 2 2 5 125 296
206060 s at 8 0 4 22263 22263 30 37
205790 at 8 0 4 22260 22262 58 44
200665 s at 8 0 4 22264 22264 27 35
207641 at 16 0,125 8 22261 22260 39 128
207540 s at 16 0,125 8 22266 22268 44 31
204430 s at 16 0,125 8 22265 22266 32 28
203471 s at 32 0,25 16 22267 22265 10 24
204951 at 32 0,25 16 22268 22267 12 14
207968 s at 32 0,25 16 22262 22261 42 184
AFFX-r2-TagA at 64 0,5 32 22270 22272 20 32
AFFX-r2-TagB at 64 0,5 32 22269 22271 19 30
AFFX-r2-TagC at 64 0,5 32 22298 22300 9 8
AFFX-r2-TagD at 128 1 64 22283 22291 1 2
AFFX-r2-TagE at 128 1 64 22295 22285 2 10
AFFX-r2-TagF at 128 1 64 22286 22284 6 5
AFFX-r2-TagG at 256 2 128 22291 22278 7 11
AFFX-r2-TagH at 256 2 128 22288 22296 14 6
AFFX-DapX-3 at 256 2 128 22289 22277 4 12
AFFX-LysX-3 at 512 4 256 22271 22274 35 50
AFFX-PheX-3 at 512 4 256 22280 22275 23 27
AFFX-ThrX-3 at 512 4 256 22278 22297 21 7
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Conclusions and remarks
4.1 Conclusions
4.1.1 RIP-Chip data analysis
• Microarray quality controls must be applied to Affymetrix microarrays
and serve as an indication wether the microarrays quality is good, or
if one or more microarray data sets should be excluded in order to
have more confident final results. For the PTB and U2AF65 RIP-Chip
microarrays all the chips were considered to have good quality.
• The three pre-processing methods applied to PTB and U2AF65 RIP-
Chip microarray data produced different data distributions, that may
lead to different results in further enriched gene selection affecting the
quality of the biological conclusions from the RIP-Chip experiment.
• The three differentially expressed gene selection methods: fitting a lin-
ear model - eBayes, Fold Change t-statistic and Rank Products (RP),
show differences in the number of enriched genes selected, being Rank
Products the most conservative. Therefore, each applied method has
different false positive and false negative associated levels. In general,
the applied methods may have a high false negative percentage.
• These three differentially expressed gene selection methods selected si-
multaneously a few amount of common genes and most of the enriched
genes were selected for one specific method, which involves problems in
the accuracy of the results, important aspect when those results must
support biological conclusions and further experiments. It is important
to point out that in the RIP-Chip experiments more that 20% of the
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genes should be enriched and therefore, the assumption of few expres-
sion differences between experimental conditions is not fulfilled, likely
affecting the performance of this methods when applied for enriched
gene selection.
4.1.2 New methods for RIP-Chip data analysis
• A linear Sequence-Specific affinity model for background correction of
gene expression Affymetrix arrays [Barreto-Hernandez et al., 2011] was
implemented. It fits binding affinities to the sequence composition by
examining the PM signal intensity, the contribution of each nucleotide
in each sequence position and the effect of adenine, thymine, cytosine,
guanine (ATCG) nucleotides count. This model is computing demand-
ing in terms of memory and time and accounted for 3 to 4% of the
variation in the arrays.
• The contribution of each nucleotide in each sequence position to the
binding affinity plus its interaction with the neighbor nucleotides were
included in the Sequence-Specific affinity model obtaining better fitting
results when the number of interacting nucleotides is increased, but
rises the computing demanding in terms of memory and time.
• The iterative process implemented using the Sequence-Specific affinity
model with 3 nucleotides interaction accounted for 42 to 58% of the
variation in the arrays explained, improved the model fit. Mainly, this
process which residuals were approximately normally distributed re-
moves high intensity values and increases the proportion of non-specific
hybridized probes in the sample data, making the final fitted model
more specific to the non-specific hybridization.
• The t-values obtained after standardization for each probe made on
each array independently do not require further normalization and
could be compared directly.
• A probe set score (PSsco) was proposed as a summarization value of
the probe set in the Affymetrix microarray and calculated pooling all
t-values from a specific probe set across all replicates. The higher the
number of replicates, the higher will be the prediction confidence.
• The probe set enriched value (ENRval) and its p-value was proposed
and allowed a consistent enriched gene selection using the U2AF65 RIP-
Chip microarray data. Selected genes include some verified experimen-
tally as targets of the U2AF65.
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• A new rank based approach was implemented for enriched gene se-
lection based in taking into account the standardized probe intensity
(t-values) variability in each probe set, corresponding to a specific gene,
instead of the usual summarization of each probe set and the poste-
rior ENRval calculation. The method selected less enriched genes that
ENRval method, but shared a higher percentage of the genes reported
in [Gama-Carvalho et al., 2006] than the genes share by the ENRval.
The list of enriched genes includes the genes verified by real time PCR
(RT-PCR) as targets of the U2AF65 by Gama-Carvalho et al. [2006].
• The method proposed uses the standardized probe intensity levels from
the individual information of each array, making possible to compare
arrays from different conditions in a more adequate way for RIP-Chip
experiments.
• The developed methods were benchmarked using the data of U133
Spike-In experiment [Cope et al., 2004], showing that they have bet-
ter accuracy when the gene expression differences are high for both
of them: ENRval and the new ranks approach methods. When the
concentration differences are small, the accuracy decreases.
4.2 Some remarks
• A future direction will be to improve the Sequence-Specific probe affin-
ity model, making it more accurate and less computing power demand-
ing.
• Develop more accurate non-parametric gene selection methods using
the probe t-values.
• The enriched gene selection method requires adjustments to make it
more sensitive and precise. Those adjustments could be made to im-
prove the background correction model, to apply other types of trim-
ming for the summarization and calculation of the ENRvals or try other
ways to measure the variability of the probe set trying to improve the
sensibility of the new ranks approach for enriched gene selection.
• The further work could consider the mixture of part of the methodol-
ogy proposed in this thesis with other methods, which are commonly
applied in microarray data analysis.
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• It is evident that there is space for improving the unspecific hybridiza-
tion prediction and in this way improving the background correction.
Most important, is that there is the possibility of obtaining better ap-
proaches of using the data of the high density microarrays for its own
pre-processing, facilitating the microarrays comparison.
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R Scripts
A.1 RIP-Chip data analysis
A.1.1 Quality Assesment
Affymetrix .CEL files reading and image plots
# Affymetrix libraries
#
library(affy)
library(affyPLM)
library(’RColorBrewer’)
bs.cols <- brewer.pal (6, ’Set1’)
# Affymetrix read data
#
da=ReadAffy()
colnames(exprs(da))<- c("Input 1","IP 1","Input 2",
"IP 2","Input 3","IP 3")
sampleNames(da) <- c("Input 1","IP 1","Input 2",
"IP 2","Input 3","IP 3")
ls.names <- sampleNames(da)
# Affymetrix quality control
#
# Images
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Sys.setenv("DISPLAY"=":0")
#jpeg(file="chipsU.jpeg",bg="white", quality=100,
res=10000)
png(file="chipsU.png", width = 800, height = 800 )
par(mfrow=c(3,2))
image (da)
dev.off()
Boxplot and density plot
# Construct color boxplots
Sys.setenv("DISPLAY"=":0")
png(file="unp-boxplotU.png", width = 800,
height = 800 )
boxplot(da, col=bs.cols, ylab=’Unprocessed log2
Probe Intensities’,
xlab=’RIP-Chip Arrays’)
title(main="Box Plots - U2AF RIP-Chip Arrys")
dev.off()
# Construct density plots
Sys.setenv("DISPLAY"=":0")
png(file="unp-DensityU.png", width = 800,
height = 800 )
hist (da, col=bs.cols, lty=1, xlab="Log2 Intensities",
lwd=3)
legend (10,.4, legend=ls.names, lty=1, col=bs.cols,
lwd=3)
title(main="Histograms (Density) Plots - U2AF
RIP-Chip Arrys")
dev.off()
MAplots
# MA plots
Sys.setenv("DISPLAY"=":0")
png(file="unMAplotU.png", width = 1200,
height = 800 )
par(mfrow=c(2, 3))
MAplot(da)
dev.off()
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RNA degradations plots
#
# RNA degradation
#
rnadeg=AffyRNAdeg(da)
Sys.setenv("DISPLAY"=":0")
png(file="RNAdegraU.png", width = 800, height = 800 )
plotAffyRNAdeg(rnadeg,col=bs.cols)
legend (7, 6, legend=ls.names, lty=1, col=bs.cols, lwd=3)
dev.off()
write.table(summaryAffyRNAdeg(rnadeg,
signif.digits = 3),file="RNA_Degradation_Sumary.txt")
PLM plots
#
#PROBE-LEVELMODELS
#
PLMda <- fitPLM(da)
# residuals PLM
#
Sys.setenv("DISPLAY"=":0")
png(file="WeightPLMU.png", width = 1200, height = 800 )
par(mfrow=c(2, 3))
image (PLMda, type="resids")
dev.off()
# weights PLM
#
Sys.setenv("DISPLAY"=":0")
png(file="ResiduesPLMU.png", width = 1200, height = 800 )
par(mfrow=c(2, 3))
image (PLMda, type="weights")
dev.off()
# Signed Residulas PLM
#
Sys.setenv("DISPLAY"=":0")
png(file="SignResiPLMU.png", width = 1200, height = 800 )
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par(mfrow=c(2, 3))
image (PLMda, type="sign.resids")
dev.off()
# RLE boxplots PLM
#
Sys.setenv("DISPLAY"=":0")
png(file="RLEU.png", width = 800, height = 800 )
RLE(PLMda, col=bs.cols, main="U2AF RLE Plot")
dev.off()
# NUSE boxplots PLM
#
Sys.setenv("DISPLAY"=":0")
png(file="NUSEU.png", width = 800, height = 800 )
NUSE(PLMda, col=bs.cols, main="U2AF NUSE Plot")
dev.off()
A.1.2 Preprocessing
Backgroung correction, Normalization and summarization
# Preprocesing RMA
#
da2=rma(da)
e2=exprs(da2)
# Preprocesing GCRMA
#
da4 <- gcrma(da)
# Preprocesing Li Wong
#
da5 <- expresso(da,bg.correct=FALSE, normalize.method=
"invariantset", pmcorrect.method="pmonly", summary.method="liwong")
da6=exprs(da5)
#Boxplots
Sys.setenv("DISPLAY"=":0")
png(file="boxplotNU.png", width = 1200, height = 800 )
par(mfrow=c(2, 2))
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boxplot(da, col=bs.cols, ylab=’ log2 Probe Intensities’, xlab=
’ U2AF RIP-Chip Arrays’)
title(main="Row data")
boxplot(da2, col=bs.cols, ylab=’ log2 Probe Intensities’, xlab=
’ U2AF RIP-Chip Arrays’)
title(main="RMA")
boxplot(da4, col=bs.cols, ylab=’log2 Probe Intensities’, xlab=
’U2AF RIP-Chip Arrays’)
title(main="GCRMA")
boxplot(log2(da6), col=bs.cols, ylab=’ log2 Probe Intensities’,
xlab=’U2AF RIP-Chip Arrays’)
title(main="Li Wong")
dev.off()
Enriched gene selection
# Limma- eBayes
library(limma)
design <- model.matrix(~ -1+factor(c(1,2,1,2,1,2)))
colnames(design) <- c("C", "TU")
fit <- lmFit(e2, design)
contrast.matrix <- makeContrasts(TU-C, levels=design)
fit2 <- contrasts.fit(fit, contrast.matrix)
fit2 <- eBayes(fit2) results <- decideTests(fit2)
# Rank Products
library(RankProd)
e2.origen=c(1,1,1,1,1,1)
e2.cl=c(0,1,0,1,0,1)
RP.adv.out <- RPadvance(e2,e2.cl,e2.origen,num.perm=100,
gene.names=rownames(e2),logged=TRUE,rand=123)
topRP=topGene(RP.adv.out,cutoff=0.05,logged=TRUE,logbase=2,
gene.names=row)
A.2 New methods for RIP-Chip data analy-
sis
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A.2.1 Sequence-specific affinity model
Sequence-specific affinity model
# Model setup
resample <- function(x, size, ...)
if(length(x) <= 1) { if(!missing(size) && size == 0) x[FALSE]
else x } else sample(x, size, ...)
#Read tables
logPM1 <- read.table("logPM.txt")
AN1 <- read.table("A_C_F_pm.txt")
TN1 <- read.table("T_C_F_pm.txt")
GN1 <- read.table("G_C_F_pm.txt")
CN1 <- read.table("C_C_F_pm.txt")
S251 <- read.table("SEQ_ARRAY_1_25_pm_C_F.txt")
logPM <- logPM1[,j]
AN <- AN1[,1]^2
TN <- TN1[,1]^2
GN <- GN1[,1]^2
CN <- CN1[,1]^2
S1 <- S251[,1]
S2 <- S251[,2]
S3 <- S251[,3]
S4 <- S251[,4]
S5 <- S251[,5]
S6 <- S251[,6]
S7 <- S251[,7]
S8 <- S251[,8]
S9 <- S251[,9]
S10 <- S251[,10]
S11 <- S251[,11]
S12 <- S251[,12]
S13 <- S251[,13]
S14 <- S251[,14]
S15 <- S251[,15]
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S16 <- S251[,16]
S17 <- S251[,17]
S18 <- S251[,18]
S19 <- S251[,19]
S20 <- S251[,20]
S21 <- S251[,21]
S22 <- S251[,22]
S23 <- S251[,23]
S24 <- S251[,24]
S25 <- S251[,25]
n=100000
Set300 <- sample(ss<-1:length(logPM),n)
logPM <- logPM[Set300]
# para reducir memoria
AN <- AN[Set300]
TN <- TN[Set300]
GN <- GN[Set300]
CN <- CN[Set300]
S1 <- S1[Set300]
S2 <- S2[Set300]
S3 <- S3[Set300]
S4 <- S4[Set300]
S5 <- S5[Set300]
S6 <- S6[Set300]
S7 <- S7[Set300]
S8 <- S8[Set300]
S9 <- S9[Set300]
S10 <- S10[Set300]
S11 <- S11[Set300]
S12 <- S12[Set300]
S13 <- S13[Set300]
S14 <- S14[Set300]
S15 <- S15[Set300]
S16 <- S16[Set300]
S17 <- S17[Set300]
S18 <- S18[Set300]
S19 <- S19[Set300]
S20 <- S20[Set300]
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S21 <- S21[Set300]
S22 <- S22[Set300]
S23 <- S23[Set300]
S24 <- S24[Set300]
S25 <- S25[Set300]
#final model setup
#?k, njT ? and no T affinities
model <- lm(logPM ~ TN + S1 + S2 + S3 + S4 + S5 + S6 + S7
+ S8 + S9 + S10 + S11+ S12 + S13 + S14 + S15 + S16 + S17
+ S18 + S19 + S20 + S21 + S22 + S23+S24+S25 + AN + TN
+ GN + CN)
#no ?k, njT ? and no T affinities
model <- lm(logPM ~ TN + S1 + S2 + S3 + S4 + S5 + S6 + S7
+ S8 + S9 + S10 + S11+ S12 + S13 + S14 + S15 + S16 + S17
+ S18 + S19 + S20 + S21 + S22 + S23 +S24+S25)
#no ?k, no njT ? and no T affinities
model <- lm(logPM ~ S1 + S2 + S3 + S4 + S5 + S6 + S7 + S8
+ S9 + S10 + S11+ S12 + S13 + S14 + S15 + S16 + S17 + S18
+ S19 + S20 + S21 + S22 + S23 +S24+S25)
#?k, no njT ? and T affinities
model <- lm(logPM ~ S1 + S2 + S3 + S4 + S5 + S6 + S7 + S8
+ S9 + S10 + S11+ S12 + S13 + S14 + S15 + S16 + S17 + S18
+ S19 + S20 + S21 + S22 + S23 +S24+S25 + AN + TN + GN + CN)
summary(model)
Sys.setenv("DISPLAY"=":0")
jpeg(file="ALL_MM_seq_noTN_3NUcleo.jpeg",bg="white",
quality=100, res=10000)
opar <- par(mfrow = c(2,2), oma = c(0, 0, 1.1, 0))
plot(model, las = 1) # Residuals, Fitted, ...
par(opar)
dev.off()
Sequence interaction model setup
# different probe interactions. 1 to 4 probes interactions
model <- lm(logPM ~ S1 +S2 + S3 + S4 + S5 + S6 + S7 + S8
+ S9 + S10 + S11 + S12 + S13 +S14 + S15 + S16 + S17 + S18
+ S19 + S20 + S21 + S22 + S23 + S24 + S25 + AN2 + TN2
+ GN2 + CN2,subset=Set300)
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summary(model)
Sys.setenv("DISPLAY"=":0")
jpeg(file="ALL_PM_seq_noTN.jpeg",bg="white", quality=100,
res=10000)
opar <- par(mfrow = c(2,2), oma = c(0, 0, 1.1, 0))
plot(model, las = 1) # Residuals, Fitted, ...
par(opar)
dev.off()
model <- lm(logPM ~ S1:S2 + S2:S3 + S3:S4 + S4:S5 + S5 : S6
+ S6 : S7 + S7 : S8 + S8 : S9 + S9 : S10 + S10 : S11 + S11 : S12
+ S12 : S13 + S13 :S14 + S14 : S15 + S15 : S16 + S16 : S17
+ S17 : S18 + S18 : S19 + S19 : S20 + S20 : S21 + S21 : S22
+ S22 : S23 + S23 : S24 + S24 : S25 + AN2 + TN2 +
GN2 + CN2,subset=Set300)
summary(model)
Sys.setenv("DISPLAY"=":0")
jpeg(file="ALL_PM_seq_noTN_2NUcleo.jpeg",bg="white",
quality=100, res=10000)
opar <- par(mfrow = c(2,2), oma = c(0, 0, 1.1, 0))
plot(model, las = 1) # Residuals, Fitted, ...
par(opar)
dev.off()
Set300 <- sample(ss<-1:length(logPM),20000)
model <- lm(logPM ~ S1:S2:S3 + S2:S3:S4 + S3:S4:S5 +
S4:S5:S6 + S5 : S6:S7 + S6 : S7:S8 + S7 : S8:S9 + S8 : S9:S10
+ S9 : S10:S11 + S10 : S11:S12 + S11 : S12:S13 +
S12 : S13:S14 + S13 :S14:S15 + S14 : S15:S16 + S15 : S16:S17
+ S16 : S17:S18 + S17 : S18:S19 + S18 : S19:S20 + S19 : S20:S21 +
S20 : S21:S22 + S21 : S22:S23 + S22 : S23:S24 + S23 : S24:S25
+ S24 : S25 + AN2 + TN2 + GN2 + CN2,subset=Set300)
summary(model)
Sys.setenv("DISPLAY"=":0")
jpeg(file="ALL_PM_seq_noTN_3NUcleo.jpeg",bg="white",
quality=100, res=10000)
opar <- par(mfrow = c(2,2), oma = c(0, 0, 1.1, 0))
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plot(model, las = 1) # Residuals, Fitted, ...
par(opar)
dev.off()
Set300 <- sample(ss<-1:length(logPM),10000)
model <- glm(logPM ~ S1:S2:S3 + S2:S3:S4 + S3:S4:S5 +
S4:S5:S6 + S5 : S6:S7 + S6 : S7:S8 + S7 : S8:S9 + S8 : S9:S10
+ S9 : S10:S11 + S10 : S11:S12 + S11 : S12:S13 + S12 : S13:S14
+ S13 :S14:S15 + S14 : S15:S16 + S15 : S16:S17 + S16 : S17:S18
+ S17 : S18:S19 + S18 : S19:S20 + S19 : S20:S21 + S20 : S21:S22
+ S21 : S22:S23 + S22 : S23:S24 + S23 : S24:S25 + S24 : S25 +
AN2 + TN2 + GN2 + CN2,subset=Set300)
summary(model)
Sys.setenv("DISPLAY"=":0")
jpeg(file="ALL_PM_glm_seq_noTN_3NUcleo.jpeg",bg="white",
quality=100, res=10000)
opar <- par(mfrow = c(2,2), oma = c(0, 0, 1.1, 0))
plot(model, las = 1) # Residuals, Fitted, ...
par(opar)
dev.off()
Set300 <- sample(ss<-1:length(logPM),8000)
model <- lm(logPM ~ S1 :S2 : S3 : S4 + S2 : S3 : S4 : S5 +
S3 : S4 : S5 : S6 + S4 : S5 : S6 : S7 + S5 : S6 : S7 : S8 +
S6 : S7 : S8 : S9 + S7 : S8 : S9 : S10 + S8 : S9 : S10 : S11
+ S9 : S10 : S11 : S12 + S10 : S11 : S12 : S13 +
S11 : S12 : S13 :S14 + S12 : S13 :S14 : S15 +
S13 :S14 : S15 : S16 + S14 : S15 : S16 : S17 +
S15 : S16 : S17 : S18 + S16 : S17 : S18 : S19
+ S17 : S18 : S19 : S20 + S18 : S19 : S20 : S21
+ S19 : S20 : S21 : S22 + S20 : S21 : S22 : S23 +
S21 : S22 :S23: S24 + S22 :S23: S24 : S25 + AN + TN + GN +
CN,subset=Set300)
summary(model)
Sys.setenv("DISPLAY"=":0")
jpeg(file="../PM/ALL_PM_glm_seq_noTN_4NUcleo.jpeg",
bg="white", quality=100, res=10000)
opar <- par(mfrow = c(2,2), oma = c(0, 0, 1.1, 0))
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plot(model, las = 1) # Residuals, Fitted, ...
par(opar)
dev.off()
3 nucleotides interaction model implementation
resample <- function(x, size, ...)
if(length(x) <= 1) { if(!missing(size) && size == 0) x[FALSE]
else x } else sample(x, size, ...)
logPM1 <- read.table("logU2AFpm.txt")
AN1 <- read.table("ANpm.txt")
TN1 <- read.table("TNpm.txt")
GN1 <- read.table("GNpm.txt")
CN1 <- read.table("CNpm.txt")
S251 <- read.table("SEQ_ARRAY_1_25_pm.txt")
for(j in 1: dim(logPM1)[2]){
logPM <- logPM1[,j]
print(paste ("slide_",as.character(j)))
# para reducir memoria
AN <- AN1[,26]^2
TN <- TN1[,26]^2
GN <- GN1[,26]^2
CN <- CN1[,26]^2
S1 <- S251[,1]
S2 <- S251[,2]
S3 <- S251[,3]
S4 <- S251[,4]
S5 <- S251[,5]
S6 <- S251[,6]
S7 <- S251[,7]
S8 <- S251[,8]
S9 <- S251[,9]
S10 <- S251[,10]
S11 <- S251[,11]
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S12 <- S251[,12]
S13 <- S251[,13]
S14 <- S251[,14]
S15 <- S251[,15]
S16 <- S251[,16]
S17 <- S251[,17]
S18 <- S251[,18]
S19 <- S251[,19]
S20 <- S251[,20]
S21 <- S251[,21]
S22 <- S251[,22]
S23 <- S251[,23]
S24 <- S251[,24]
S25 <- S251[,25]
n=20000
Set300 <- sample(ss<-1:length(logPM),n)
x=2
xx=0
y <-0
resumen <- matrix(0,100,8)
print ("Itera_ R.squared Adj R.squared Eliminados")
while (x>0.001){
logPM <- logPM[Set300]
# para reducir memoria
AN <- AN[Set300]
TN <- TN[Set300]
GN <- GN[Set300]
CN <- CN[Set300]
S1 <- S1[Set300]
S2 <- S2[Set300]
S3 <- S3[Set300]
S4 <- S4[Set300]
S5 <- S5[Set300]
S6 <- S6[Set300]
S7 <- S7[Set300]
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S8 <- S8[Set300]
S9 <- S9[Set300]
S10 <- S10[Set300]
S11 <- S11[Set300]
S12 <- S12[Set300]
S13 <- S13[Set300]
S14 <- S14[Set300]
S15 <- S15[Set300]
S16 <- S16[Set300]
S17 <- S17[Set300]
S18 <- S18[Set300]
S19 <- S19[Set300]
S20 <- S20[Set300]
S21 <- S21[Set300]
S22 <- S22[Set300]
S23 <- S23[Set300]
S24 <- S24[Set300]
S25 <- S25[Set300]
model <- lm(logPM ~ S1:S2:S3 + S2:S3:S4 +
S3:S4:S5 + S4:S5:S6 + S5 : S6:S7 + S6 : S7:S8
+ S7 : S8:S9 + S8 : S9:S10 + S9 : S10:S11 +
S10 : S11:S12 + S11 : S12:S13 + S12 : S13:S14
+ S13 :S14:S15 + S14 : S15:S16 + S15 : S16:S17 +
S16 : S17:S18 + S17 : S18:S19 + S18 : S19:S20
+ S19 : S20:S21 + S20 : S21:S22 + S21 : S22:S23
+ S22 : S23:S24 + S23 : S24:S25 + AN + TN + GN
+ CN)
summodel <- summary(model)
quantilResiduals <- quantile (summodel$residuals)
dquantiles <- quantilResiduals[4]-quantilResiduals[2]
# outliers limits
MenorLimite <- quantilResiduals[2]-(1.5* dquantiles)
MayorLimite <- quantilResiduals[4]+(1.5* dquantiles)
Set300 <-as.numeric(names(resample(residuals(model)
[residuals(model)< MayorLimite & residuals(model)>
MenorLimite])))
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x1 <- n - length(Set300)
n <- length(Set300)
y <- y+1
resumen[y,1:5] <- quantile (summodel$residuals)
#print ("Residual Quantiles:")
#print (quantile (summodel$residuals))
print (paste(as.character(y)," ",as.character
(summodel$r.squared)," ",as.character(summodel
$adj.r.squared)," ",as.character(x1)))
resumen[y,6] <- summodel$r.squared
if (y > 1){
x <-resumen[y,6]-resumen[y-1,6]
}
if (resumen[y,6]>=0.75 & xx==0) {
xx=1
}
resumen[y,7] <- summodel$adj.r.squared
resumen[y,8] <- x1
if (y==1 | x<=0.001 | xx==1){
if (y==1) {
res <- paste ("PM_LIM_15_Histo_Array_",
as.character(j),"_Itera1.jpeg")
}
if (x<=0.001) {
res <- paste ("PM_LIM_15_Histo_Array_",
as.character(j),"_Itera_Final.jpeg")
}
if (xx==1){
res <- paste ("PM_LIM_15_Histo_Array_",
as.character(j),"_Itera_R0.75.jpeg")
save (model,file =paste ("PM_LIM_15_
model_Array_",as.character(j),
"_Itera_R0.75.RData") )
xx <-2
}
Sys.setenv("DISPLAY"=":0")
jpeg(file=res,bg="white", quality=100, res=10000)
hist (summodel$residuals)
dev.off()
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}
}
save (model,file =paste ("PM_LIM_15_model_Array_
",as.character(j),"_Itera_Final.RData") )
write.table (resumen[1:y,], paste("PM_LIM_15_resumen_Array_
",as.character(j),".txt"))
}
A.2.2 Probe standardization: j values
logPM1 <- read.table("logU2AFpm.txt")
logPM1p <- read.table("PM_LIM_15_model_Array_ALLarrays
_Pred_PM.txt")
n1 <- round(nrow/200,0)
nrow <- dim(logPM1)[1] #probes number
ncol <- dim(logPM1)[2] # arrays number
J <- matrix(0,nrow,ncol) #j values
des <- matrix(0,round(nrow/n,0),7*ncol) # bins number
for(j in 1: ncol){
print(paste ("slide_",as.character(j)))
#calculo de los sd de los bin de 3000 cada uno
binLogPm1 <- matrix(0,nrow,4)
binLogPm1[,1] <- 1:nrow
binLogPm1 [,2]<- logPM1[,j]
binLogPm1 [,3]<- logPM1p[,j]
binLogPm1<- binLogPm1[order(binLogPm1[,3]),]
for(z in 0 : ((nrow/n1)-1)) {
p <- z*n1+1
p1 <- ifelse (z == round(((nrow/n1)-1),0), nrow,
(z+1)*n1)
binLogPm1 [p:p1,4]<- sd (binLogPm1 [p:p1,2])
des[(z+1),(7*(j-1)+1):(j*7-2)] <- quantile(binLogPm1
[p:p1,2])
des[(z+1),(j*7-1)] <- sd (binLogPm1 [p:p1,2])
des[(z+1),(j*7)] <- mean (binLogPm1 [p:p1,2])
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}
#j values calculation
binLogPm1<- binLogPm1[order(binLogPm1[,1]),]
J[,j] <- (logPM1[,j]-logPM1p [,j] )/binLogPm1[,4]
}
write.table(des,"PM_LIM_15_model_Array_ALLarrays_
IntervalsCorrectLogPM.txt")
write.table(J,"PM_LIM_15_model_Array_ALLarrays_Jmat_
Corect.txt")
A.2.3 ENRval values calculation
resample <- function(x, size, ...)
if(length(x) <= 1) { if(!missing(size) && size == 0)
x[FALSE] else x
} else sample(x, size, ...)
PS <- read.table (paste(PathTablas,"HG-U133A_tag_
ProbeSequenceOrder.txt",sep=""), skip = 1)
PS<- PS[,2]
names (PS)<- 1:length(PS)
#Read $t$ values
J <- read.table(paste(PathResults,"ALLarrays_Jmat_Corect1.txt",
sep=""))
J <- J[,J11]
IP <-levels(PS)
nProbeSet <- length(IP)
Exp <- c("T","I","T","I","T","I")
nInput <- length(resample(Exp[Exp == "T"]))
nIp <- length(resample(Exp[Exp == "I"]))
muestra <- c(1,1,2,2,3,3)
nArray <-dim(J)[2]
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J_Ind_trim <- matrix(NA, nProbeSet,(nIp*3)) #individual PSsco
J_trim <- matrix(NA, nProbeSet,11) #ENRval replicates
for (i in 1:nProbeSet){
print (i)
Set300 <-sort(as.numeric(names(resample(PS[PS ==
IP[i]]))))
nProbes <- length(Set300)
nProbes10 <- round ((nProbes*0.1),0)
#trimmed PSsco
J1 <- rep (0, (nProbes*nInput)) # arrays Input
J2 <- rep (0, (nProbes*nIp)) # arrays Ip
c <-0 # array possition J1
c1 <- 0 # array possitio J2
c3 <- 0 # array possitio J_Ind_trim
for (j in 1: nArray){
#PSsco Ip individuals
Jaux <- J[Set300,j]
Jaux <- Jaux[order(Jaux)]
if(Exp[j]=="T"){
J1[(c+1):(c+ nProbes)] <- Jaux
c <- c + nProbes
}
else{
c3 <- c3 +1
J_Ind_trim[i,c3]<-sqrt(nProbes-(nProbes10*2))
*mean(Jaux[(1+ nProbes10): (
nProbes-nProbes10)])
J2[(c1+1):(c1+ nProbes)] <- Jaux #
c1 <- c1 + nProbes
}
}
nProbes <- length(J1)
nProbes10 <- round ((length(J1)*0.1),0)
Jaux <- J1
Jaux <- Jaux[order(Jaux)]
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#PSsco J_trim col 1 = Input
J_trim[i,1]<-sqrt(length(J1)-(nProbes10*2))*mean(Jaux[(1
+ nProbes10):
(nProbes-nProbes10)])
#PSsco J_trim col2 = sd trimmed Input
J_trim[i,2]<- sd(Jaux[(1+ nProbes10): (nProbes-nProbes10)])
nProbes <- length(J2)
nProbes10 <- round ((length(J2)*0.1),0)
Jaux <- J2
Jaux <- Jaux[order(Jaux)]
#PSsco J_trim col3 = Ip
J_trim[i,3]<-sqrt(length(J2)-(nProbes10*2))*mean(Jaux[(1
+ nProbes10):
(nProbes-nProbes10)])
#PSsco J_trim col6 = IP - Input
J_trim[i,6]<- J_trim[i,3] - J_trim[i,1]
#PSsco J_trim col9 = (IP - Input)/ sd trimmed Input
J_trim[i,9]<- J_trim[i,6] / J_trim[i,2]
}
# Pvalue and FDR individual array Ip
for (i in 1:nIp){
MedIp <- median(J_Ind_trim[,i])
SDIp <- sd (resample (J_Ind_trim[J_Ind_trim[,i] <= MedIp,i]))
J_Ind_trim[,(nIp+(2*i-1))]<-1-pnorm(J_Ind_trim[,i], mean=
MedIp, sd=SDIp, log = FALSE) #Pvalue
for (j in 1:nProbeSet){
if (J_Ind_trim[j,i]> MedIp){ #FDR >s 0
J_Ind_trim[j,(nIp+(2*i))] <- length (resample
(J_Ind_trim[J_Ind_trim[,i] < -
(J_Ind_trim[j,i]-MedIp),i])) / length(resample
(J_Ind_trim[J_Ind_trim[,i] >= J_Ind_trim[j,i],i]))
}
}
}
#Pvalie J_trim col 4 = Ip
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MedIp2 <- median(J_trim[,3])
#SDIp <- sd (resample (J_trim[J_trim[,3] <= MedIp2,3]))
SDIp <- sd (c(resample (J_trim[J_trim[,3] <= MedIp2,3]),(
-resample (J_trim[J_trim[,3] <=
MedIp2,3])+(2* MedIp2))))
J_trim[,4]<-1-pnorm(J_trim[,3], mean=MedIp2, sd=SDIp,
log = FALSE)
#Pvalie J_trim col 8 = Ip - Input
MedIp3 <- median(J_trim[,6])
#SDIp <- sd (resample (J_trim[J_trim[,6] <= MedIp3,6]))
SDIp <- sd (c(resample (J_trim[J_trim[,6] <= MedIp3,6]),(
-resample (J_trim[J_trim[,6] <= MedIp3,6])+(2* MedIp3))))
J_trim[,7]<-1-pnorm(J_trim[,6], mean=MedIp3, sd=SDIp,
log = FALSE)
#Pvalie J_trim col 10 = Ip - Input/ sd Input
MedIp5 <- median(J_trim[,9])
#SDIp <- sd (resample (J_trim[J_trim[,9] <= MedIp5,9]))
SDIp <- sd (c(resample (J_trim[J_trim[,9] <= MedIp5,9]),
(-resample (J_trim[J_trim[,9] <= MedIp5,9])+(2* MedIp5))))
J_trim[,10]<-1-pnorm(J_trim[,9], mean=MedIp5, sd=SDIp, log =
FALSE)
#calculo FDR
for (i in 1:nProbeSet){
if (J_trim[i,3]> MedIp2){ #FDR > 0
J_trim[i,5]<-length(resample (J_trim[J_trim[,3]
< -(J_trim[i,3]-MedIp2),3]))/length(resample
(J_trim[J_trim[,3] >= J_trim[i,3],3]))
}
if (J_trim[i,6]> MedIp3){ #FDR > 0
J_trim[i,8]<-length(resample (J_trim[J_trim[,6]
< -(J_trim[i,6]-MedIp3),6]))/length(resample
(J_trim[J_trim[,6] >= J_trim[i,6],6]))
}
if (J_trim[i,9]> MedIp5){ #FDR > 0
J_trim[i,11]<-length(resample (J_trim[J_trim[,9]
< -(J_trim[i,9]-MedIp5),9]))/length(resample
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(J_trim[J_trim[,9] >= J_trim[i,9],9]))
}
}
# tables tx
write.table(J_Ind_trim,paste(PathResults,"PSsco_ind.txt",sep=""))
#write.table(J_trim,"./AnovaENR_trimmed/PSsco_c1.txt")
write.table(J_trim,paste(PathResults,"PSsco_c1_SD.txt",sep=""))
# summary table of probe set
#write.table(probeset,"PM_Probeset_J_NoIP.txt")
#plot (J[Set300,4],type = "l",col = "red")
#points(J[Set300,4], cex = .5, col = "dark red")
# Sys.setenv("DISPLAY"=":0")
# jpeg(file=res,bg="white", quality=100, res=
10000)
# hist (summodel$residuals)
# dev.off()
A.2.4 New rank based approach for enriched gene se-
lection.
resample <- function(x, size, ...)
if(length(x) <= 1) { if(!missing(size) && size == 0) x[FALSE] else x
} else sample(x, size, ...)
PS <- read.table ("/Users/ebarretoh/Documents/POSGRADO
/estatistica/Datos_Margarida
/LocalMAT/spikeIN/Tablas/HG-U133A_tag_
ProbeSequenceOrder.txt", skip = 1)
PS<- PS[,2]
names (PS)<- 1:length(PS)
J <- read.table("/Users/ebarretoh/Documents/POSGRADO/
estatistica/Datos_Margarida
/LocalMAT/spikeIN/results/PM/PM_LIM_15_model_Array_
ALLarrays_Jmat_Corect1.txt")
J11 <-c(14,1,28,15,42,29)
J <- J[,J11]
IP <- levels(PS)
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nProbeSet <- length(IP)
Exp <- c("T","I","T","I","T","I")
nInput <- length(resample(Exp[Exp == "T"]))
nIp <- length(resample(Exp[Exp == "I"]))
muestra <- c(1,1,2,2,3,3)
nArray <-dim(J)[2]
J_trim <- matrix(0, nProbeSet,9) # array ranks results
names (J_trim) <- nProbeSet
for (i in 1:nProbeSet){
print(i)
Set300 <-sort(as.numeric(names(resample(PS[PS ==
IP[i]]))))
nProbes <- length(Set300)
nProbes10 <- round ((nProbes*0.1),0)
#trimmed PSsco
J1 <- rep (0, (nProbes*nInput)) # arrays Input
J2 <- rep (0, (nProbes*nIp)) # arrays Ip
c <-0 # posicion arreglo J1
c1 <- 0 # posicion arreglo J2
for (j in 1: nArray){
Jaux <- J[Set300,j]
if(Exp[j]=="T"){
J1[(c+1):(c+ nProbes)] <- Jaux
c <- c + nProbes
}
else{
J2[(c1+1):(c1+ nProbes)] <- Jaux #
c1 <- c1 + nProbes
}
}
J1 <- J2 -J
nProbes <- length(J1)
nProbes10 <- round ((length(J1)*0.1),0)
Jaux <- J1
Jaux <- Jaux[order(Jaux)]
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J1 <- Jaux[(1+ nProbes10): (nProbes-nProbes10)]
# col1 TPj mean
J_trim[i,1]<-mean(J1)
c <-0 # option array J1
J_trim[i,2] <-0
J_trim[i,3] <-0
for (j in 1: (nArray/2)){
Jaux1<-J1[(c+1):(c+ nProbes)]
Jaux2 <- mean(Jaux1)
#col2 TPsjnAr
J_trim[i,2]<-J_trim[i,2] + abs(Jaux2 - J_trim[i,1])
#col3 TPssj
J_trim[i,3]<-J_trim[i,3] + (sum(abs(Jaux1-Jaux2))
/nProbes)
c <- c + nProbes
}
#col2 TPsj
J_trim[i,2]<-J_trim[i,1] - (J_trim[i,2]/(nArray/2))
#col3 TPssj
J_trim[i,3]<-J_trim[i,1]- (J_trim[i,3]/(nArray/2))
#col4 TPsj
J_trim[i,4]<-(2*J_trim[i,1]) - J_trim[i,2]
#col5 TPssj
J_trim[i,5]<-(2*J_trim[i,1]) - J_trim[i,3]
}
# Total Rank RT
J_trim[,6] <- (nProbeSet+1- rank (J_trim[,2]))*(nProbeSet+1-rank
(J_trim[,3]))*(nProbeSet+
1- rank (J_trim[,4]))*(nProbeSet+1- rank (J_trim[,5]))/nProbeSet^4
# Estipular M
M=100
#----- permutations-------------------------
rp<-matrix(0, nProbeSet,M)
for(t in 1:M)
{
print (t)
rp[,t] <- (nProbeSet+1-rank (resample(J_trim[,2]))) *
(nProbeSet+1-rank (resample
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(J_trim[,3]))) * (nProbeSet+1-rank (resample(J_trim[,4])))
*(nProbeSet+1-rank (resample(J_trim[,5])))/nProbeSet^4
}
# average expected value" E(rp)~x(rp)/M
#
J_trim[,7]<-0
for(i in 1: nProbeSet)
{
print(i)
# col5 E value
count<-0
for(j in 1: M)
count <- count + length(resample (rp[rp[,j] <= J_trim[i,6],j]))
J_trim[i,7] <- count/M
}
# "false discovery rate" q=E(rp)/rank
#col6 FDR --- q
J_trim[,8] <- J_trim[,7]/ rank (J_trim[,6])
# p-value
J_trim[,9] <- J_trim[,7]/nProbeSet
# tablas txt
write.table(J_trim,"/Users/ebarretoh/Documents/POSGRADO/
estatistica/Datos_Margarida
/LocalMAT/spikeIN/results/PM/Ranks_Subset_Suma_resta
_trim.txt")
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